In June of 1984, a seminal scientific meeting entitled "Transplanta-Radiotherapy of brain tumors is beneficial, but can cause debilitattion in the Mammalian CNS" was held in Sweden. This meeting ing side effects on cognitive function. Nearly 200,000 patients/year brought together the world leaders in the field of neurological repair receiving cranial radiotherapy are at risk for developing cognitive dysto address the state of knowledge regarding the biology underlying the function, especially pediatric patients can lose up to 3 IQ/year. Curresponse of the CNS to neural transplantation. This meeting also rently, there are no satisfactory, long-term solutions for this serious marked the first forum assessing the therapeutic prospects for grafted side effect. Radiation-induced stem cell depletion and the resultant incells to restore neurological function. This meeting marked the advent hibition of neurogenesis is one of the pathogenic explanations for cogof a new era for research into CNS repair and, following subsequent nitive decline. Previously, we successfully showed that transplanted meetings in Rochester (USA) and Cambridge (UK), these triannual human embryonic stem cells (hESCs) could reverse radiation-induced scientific congresses were established as the International Neural cognitive impairment, thereby providing the first evidence that such a Transplantation and Repair (INTR) Meetings. At the time of the 1984 strategy might hold promise to improve quality of life (Acharya et al., meeting, transplanted cells were somewhat mysterious "spare parts" PNAS, 2009). While encouraging, use of hESCs is not without risk that integrated into the circuitry with various degrees of success. The because of the possibility of teratoma formation. Thus, to circumvent CNS was seen as an immunoprivileged recipient tissue and grafted these concerns, we explored the capability of using human neural stem cells, though stimulating regeneration in certain conditions, did so by cells (hNSCs) as alternative therapeutic agents for transplantation after unknown mechanisms. Manipulating gene expression in cells through cranial irradiation. Prior to grafting, hNSCs were expanded and laex vivo or in vivo genetic therapy approaches had not yet been envibeled with bromodeoxyuridine (BrdU). Athymic nude rats subjected sioned. The existence of endogenous neural stem cells in the mature to 10 Gy head-only irradiation were transplanted 2 days afterward with CNS was a discovery (or rediscovery) that was still in the future. Now hNSCs at four distinct hippocampal sites (100,000 cells/site; 400,000 27 years later, we are again on the brink of a new era in research with cells/hemisphere). Control (nonirradiated) and irradiated animals reprogress in many areas including stem cells, epigenetic regulation, ceiving vehicle served as sham surgery groups. At 1 or 4 months postgene and cell therapy, and medicinal chemistry of small molecules.
grafting, rats were tested on hippocampal-dependent novel place rec-We have experimental and analytical tools that far surpass the reognition task. Irradiated animals exhibited significant impairment on sources available to investigators in 1984. Likewise, our understanding short-and long-term memory function compared to nonirradiated conof neurodegenerative pathophysiology and the biology of CNS regentrols. In contrast, irradiated animals transplanted with hNSCs showed eration has substantially evolved. In the 11th INTR meeting, we will significant improvements in spatial memory and cognitive perforhear of the latest advances in neurological restoration. But what key mance that was comparable to controls. These results strongly suggest areas still represent terra incognita? What fundamental understanding that hNSC grafting ameliorated radiation-induced cognitive impairof cell biology do we lack or technological barriers still exist that, ment by preserving short-and long-term hippocampal-dependent memonce overcome, will usher in new advances? What research focus will ory. Immunocytochemical analyses of brain sections from 1-and 4turn out to be truly transformative in regard to how we understand month postgrafting animals revealed extensive migration of grafted disease, injury, and regeneration in the CNS? To help us envision the cells throughout the host hippocampus. Grafted cell survival, quantianswers to these questions, the Presidential Symposium of the 11th fied by unbiased stereology, revealed that 23% and 12% of the grafted INTR meeting features perspectives from three leading scientists, Ancells survived at 1 and 4 months, respectively. These numbers indicate ders Björklund (Lund University, Sweden; one of the organizers of that as few as 100,000 surviving cells in the irradiated brain were the 1984 meeting), Ron McKay (NIH, USA), and Hideyuki Okano sufficient to ameliorate radiation-induced cognitive deficits. Dual im-(Keio University, Japan). Each speaker will present a talk describing munofluorescence analyses and confocal microscopy revealed that their perspective of our state of knowledge and the challenges that grafted hNSCs differentiate into neuronal/glial lineages. Notably, 11% need to be overcome to advance neurological repair. This will be folof the grafted hNSCs expressed behaviorally induced activity-regulowed by a forum discussion with the three speakers. We anticipate lated cytoskeleton-associated protein (Arc) and displayed neuronal the stimulating discussion that will arise from this symposium will morphology, suggesting their capability to functionally integrate into provide a conceptual roadmap that will help guide the research efforts the host hippocampus. These findings provide evidence that grafted of the next generation of investigators.
hNSCs can survive, differentiate along neural lineages, and function-Supported by a generous gift from MBF Bioscience, Inc. (www. ally integrate into the irradiated hippocampus. Importantly, engrafted mbfbioscience.com).
cells restored cognitive impairments following cranial irradiation. Therefore, stem cell-based therapy may provide a long sought after clinical intervention for reversing the adverse effects of radiotherapy on cognition that may benefit millions of cancer survivors worldwide. Supported by California Institute for Regenerative Medicine (CIRM) Grant RS1-00413 (C.L.L.), US Department of Energy Grant function in the MPTP rodent model, a critical gap. Therefore, we stud-vasive, sensitive, specific, reproducible, and cost-effective state marker for PD, especially for detection of earlier stages of the neuro-ied whether bilateral CDNF injections into striatum of C57/Bl6 mice have neuroprotective and neurorestorative properties for the nigrostria-degenerative disease. tal dopamine system after MPTP injections. We found that bilateral striatal CDNF injections, given 20 h before MPTP exposure, improved horizontal and vertical motor behavior when measured 2 weeks after-Microinjection of the GABA-Enhancing Drug Vigabatrin wards. In addition, CDNF pretreatment increased tyrosine hydroxylase in an Acute Seizure Model as a Strategy for Identifying Targets (TH) immunoreactivity in the striatum and in the substantia nigra pars for Neural Transplantation With GABA-Producing Cells reticulata (SNpr), as well as number of TH-positive cells in substantia nigra pars compacta (SNpc). Posttreatment with CDNF, given 1 week B. Backofen-Wehrhahn,* † S. Bröer,* † W. Löscher,* † after MPTP injections, increased horizontal and vertical behavior of and M. Gernert* † mice. Furthermore, dopamine fiber densities in striatum and the number of TH-positive cells in SNpc were increased after CDNF injec-*Department of Pharmacology, Toxicology, and Pharmacy, tions. We conclude that intrastriatal CDNF administration is both neu-University of Veterinary Medicine Hannover, Hannover, Germany roprotective and neurorestorative for the nigrostriatal dopamine system †Center for Systems Neuroscience Hannover, Hannover, Germany in the MPTP model, which supports the development of CDNF-based treatment strategies for Parkinson's disease.
This study was supported by the Intramural Program of the Na-Resistance to antiepileptic drugs (AEDs) is a major problem in epilepsy treatment and affects 30-40% of epileptic patients and an tional Institute on Drug Abuse. even higher portion of patients suffering from temporal lobe epilepsy. One promising approach to overcome this problem is the neural transplantation of γ-aminobutyric acid (GABA)-producing cells into appropriate target regions within the brain. Inhibition of the substantia nigra Developing MRI-Based Biomarkers for Early Diagnosis pars reticulata (SNr), a main basal ganglia output structure, has repeatof Parkinson's Disease edly been shown in experimental epilepsy to be a highly interesting approach for modulation of different seizure types emanating from the A. Andersen, P. Hardy, R. Grondin, G. Gerhardt, and Z. Zhang limbic system. The AED vigabatrin irreversibly inhibits the degradation of GABA, resulting in an elevation of the GABA concentration in the synaptic cleft. In the present study, we used microinjection of Department of Anatomy and Neurobiology, University of Kentucky vigabatrin to identify the most promising target region within the basal College of Medicine, Lexington, KY, USA ganglia network for inducing robust anticonvulsant effects by subsequent grafting of GABA-producing cells. Because pentylenetetrazole (PTZ) acts as a GABA antagonist, the PTZ seizure threshold test is Parkinson's disease (PD) is currently considered a systemic disease with complex motor disorders and nonmotor deficits that appear particularly sensitive to GABA-potentiating manipulations, thereby representing an efficient nonlaborious model for the screening of ther-before or in parallel with motor deficits and then worsen with disease progression. It has been well documented that PD is also characterized apeutic approaches that increase GABAergic inhibition. By using the timed intravenous PTZ infusion seizure threshold test, we now exam-by a long preclinical phase (from the onset of dopamine neuron loss to the onset of motor symptoms), which could last for many years or ined (1) whether and with which time course systemic application of vigabatrin is effective in the PTZ seizure threshold test, (2) whether even decades. Thus, there is an urgent need to develop imaging modality to screen individuals who may be in the preclinical phase of PD and with which time course local application of vigabatrin into functionally distinct subregions of the SNr is anticonvulsant, and (3) for earlier diagnosis and treatment to slow down or stop progression of the disease. Our group has been trying to develop magnetic resonance whether and with which time course anticonvulsant effects also occur after local application of vigabatrin into the subthalamic nucleus imaging (MRI)-based imaging biomarkers for early detection of PD because the imaging modality (MRI) is noninvasive, sensitive, spe-(STN), which in comparison to the SNr is poorly investigated as a target structure for focal epilepsy therapy. We evaluated the seizure cific, reproducible, and cost-effective. In addition, we also use MRI techniques to map a specific dopamine agonist such as apomorphine-susceptibility of adult female Wistar rats before and after systemically or locally applied vigabatrin, respectively. The PTZ seizure threshold or d-amphetamine-induced activation in a living brain. The imaging methods, called pharmacological MRI (phMRI), have demonstrated was determined at least 48 h prior to vigabatrin injection and again either 6, 24, 48, or 96 h after vigabatrin treatment. We found a signifi-that phMRI can detect functional deficiency of the nigrostriatal system by showing stronger activation in the 1-methyl-4-phenyl-1,2,3,6-tetra-cant anticonvulsant effect after systemic treatment with vigabatrin (600 mg/kg, IP), with a maximum efficacy 6 h after application. For hydropyridine (MPTP)-lesioned striatum versus the unlesioned side of the same structures in hemiparkinsonian monkeys rendered by unilat-local microinjection of vigabatrin, rats were anesthetized with isoflurane (induction 3%, maintenance 1.5%), which did not influence PTZ eral administration of MPTP (a neurotoxin for dopamine neurons) and correlate with severity of parkinsonian features (Zhang et al., 2006) . seizure threshold 6 h after anesthesia. Vigabatrin (40 µg/µl) was injected bilaterally in a volume of 250 nl into the SNr or STN, respec-We also demonstrated that phMRI can be used to monitor therapeutic effects in PD monkeys (Luan et al., 2008) . Recently, we found that tively, during surgery. Microinjection of vigabatrin into subregions of the SNr as well as into the STN clearly proved that local increase of phMRI can also detect functional deficiency of the nigrostriatal system even in asymptomatic parkinsonian monkeys in which there were no inhibition within these target regions is as effective as systemic treatment with vigabatrin. The maximum efficacy here was 24 h after mi-obvious motor deficits but with dysfunctions of the dopamine system judged by potassium-or d-amphetamine-evoked dopamine release croinjection. Our studies demonstrated that, apart from the SNr, the STN is a promising target structure for neural transplantation of measured by in vivo microdialysis, number of dopamine neurons in the midbrain, and dopamine fiber density in the striatum. The asymp-GABA-producing cells in epilepsy (see Abstract by Gernert et al., this Meeting). tomatic PD model was developed by using later middle-aged rhesus monkeys and a relatively low dose of MPTP. Those animals were Supported by a grant (GE1103/7-1) from the German Research Foundation (Bonn, Germany) . monitored up to 18 months by a computerized behavioral testing battery. The results of phMRI regarding dopamine deficiency were further validated by a positron emission tomography (PET) study with [ 11 C]DTBZ BP as a vesicular monoamine transporter-2 (VMAT-2) tracer. In the PET study, asymptomatic PD monkeys showed about 49.5% dopamine deficiency in the MPTP-lesioned putamen (unpublished pilot data). Taken together, these novel findings support the notion that phMRI effect has the potential to be developed as a nonin-potential way to improve cell survival is to incorporate the transplanted cells into a protective carrier, such as a biodegradable hydro-the behavior of endogenous stem cells. First, we looked at the effects of blocking VEGF signaling via its receptor Flk1 on both the prolifera-gel. Hydrogels have been used for decades in drug delivery and tissue reconstruction of the body, but they have only begun to be exploited tion of endogenous neural stem cells under baseline conditions and following an insult to the CNS. We determined that VEGF is neces-for use in the brain recently. Before hydrogels can be used as cell carriers in the brain two issues must be addressed: 1) What physical sary for both cycling under normal conditions and during an endogenous neural stem cell-mediated regenerative response triggered by characteristics of the hydrogel allow cells to survive and thrive on the inside? 2) How does the brain, as an organ, react to the presence of AraC administration. Next, we looked at how the lack of VEGF would affect the mitotic effects of FGF-2, as both work synergistically in the hydrogel once implanted? We have tried to address both questions in a series of papers whose main conclusions will be presented. Using other systems, and found that FGF-2 depends upon VEGF to promote its mitotic effects. These results indicate that growth factors not only hydrogels as cell carriers, we found that primary neural cell populations, derived from the forebrain of an e14-15 rat embryo, were signif-directly influence cells necessary for endogenous repair, but they may also affect how other factors function. Understanding the potential in-icantly affected by the physical stiffness (compressive modulus) of the hydrogel, affecting survival, proliferation, and the ratio of neurons to teractions of growth factors in young and aged tissue improves our understanding of endogenous repair, and provides insights necessary astrocytes to neural progenitor cells. Furthermore, at compressive modulus measures permissive for cell survival, the neural cells initially to recruit stem cells to contribute to repair.
Supported by NIH AG020047 and AG022555 to D.P. survived better when incorporated into a hydrogel carrier (3D) than when seeded on the hydrogel surface (2D); however, cells growing on neurotrophic factors, including GDNF, by increasing its expression/ excretion from activated microglia/astrocytes. Studies using the endo-the surface showed greater proliferation. When hydrogel strands were implanted into normal rodent brain, the host brain had a significantly toxin lipopolysaccharide (LPS), a potent inflammogen, show that systemic insults can trigger prolonged microglial activation and proin-attenuated neuroimmune response compared to sham implants, which were given a needle penetration only. Astrocytes and microglia were flammatory cytokine production and neuronal degeneration. LPS administration is known to lead to detrimental effects on hippocampal-found in fewer numbers around the hydrogel and typically had a less reactive morphology. While the initial compressive modulus for all dependent behaviors in rodents; however, the role of GDNF signaling for these effects has not been explored. To examine effects of the hydrogel strands remained constant, we manipulated the rate of degradation of the hydrogels implanted into the brain, using a fast degrad-combined insult of LPS and reduced GDNF receptor levels, we administered LPS (1 mg/kg, IP) once a month for 3 months starting at 7 ing, slow degrading, and a nondegrading hydrogel composition. While all hydrogels were less immunoreactive than the needle penetration, months of age to male wild-type (WT) and GDNF receptor heterozygous (Gfrα1 +/− ) mice. One month following the last LPS injection, the the neuroimmune response was significantly different between the fast degrading hydrogel and the slow or nondegrading hydrogel. In these mice underwent a battery of behavioral testing, including locomotor activity, accelerating rotarod, and water radial arm maze (WRAM), studies, we explored how cell survival and the host brain response are functions of the compressive modulus and degradability of the hydro-using a win-shift paradigm with four of the eight arms baited with escape platforms. At 10 months of age, (Gfrα1 +/− mice treated with gel. These are only two physical variables in a sea of many physical and chemical variations that are possible. Optimizing hydrogels as cell LPS demonstrated a greater reduction in motor activity compared to saline-treated (Gfrα1 +/− and LPS-treated WT mice. Furthermore, (Gfrα1 +/− carriers for transplantation into the brain may be an arduous task; however, with these studies we have begun to establish rules of thumb mice treated with LPS performed worse when tested in the WRAM than the other treatment groups, especially during trial 4, when mem-regarding at least the physical characteristics of hydrogels. Support: NIH/NINDS RO1-NS052597-01 and NS40822-01A1. ory load was highest. The impaired performance of (Gfrα1 +/− mice treated with LPS at the highest memory load was present in both the reference and working memory component of the task. The behavior data will be combined with immunohistochemical analysis to correlate Neural Stem Cells Improve Cognition Via BDNF in a Transgenic these behavioral effects with structural alterations in the limbic system.
Model of Alzheimer's Disease
Thus, these data demonstrated that memory and motor impairment following repeated LPS exposure was significantly exacerbated by a par-M. Blurton-Jones* † and F. M. LaFerla* † tial genetic reduction of Gfrα1. Neural stem cell transplantation represents an unexplored approach D. Boison for treating neurodegenerative disorders associated with cognitive decline. In Alzheimer's disease, beta-amyloid (Aβ) plaques and tau-RS Dow Neurobiology Labs, Legacy Research Institute, laden neurofibrillary tangles accumulate in several brain regions, lead-Portland OR, USA ing to synaptic dysfunction and cognitive deficits. Here we show that neural stem cells (NSCs) transplanted into the hippocampus of Alzhei-Adenosine is an endogenous anticonvulsant of the brain and is immer's transgenic mice rescue spatial learning and memory deficits. plicated in seizure termination and postictal refractoriness. Research Remarkably, cognitive function is improved without altering Aβ or tau from our lab has identified dysregulation of adenosine-based neuromopathology. Instead, the mechanism underlying the improved cognition dulation in epilepsy as a major contributor to seizure generation. Thus, involves a robust enhancement of hippocampal synaptic plasticity, meastrogliosis-a pathological hallmark of the epileptic brain-leads to diated by brain-derived neurotrophic factor (BDNF). Gain-of-function overexpression of adenosine kinase (ADK), the major adenosine mestudies show that delivery of recombinant BDNF mimics the benefitabolizing enzyme. Overexpression of ADK results in focal adenosine cial effects of NSC transplantation. Furthermore, loss-of-function studdeficiency, which per se and in the absence of any other epileptogeneies show that depletion of NSC-derived BDNF fails to improve cognitic event is sufficient to trigger seizures. Likewise, transgenic or virustion or restore synaptic plasticity. Taken together, our findings induced overexpression of ADK triggers seizures. Based on this condemonstrate that neural stem cells can ameliorate complex behavioral ceptual framework, focal adenosine augmentation therapies (AATs) deficits associated with widespread Alzheimer's disease pathology via constitute a neurochemical rationale for therapeutic intervention. To BDNF.
meet the therapeutic goal of focal adenosine augmentation, mouse and Supported by California Institute for Regenerative Medicine (CIRM).
human stem cells have been engineered to secrete adenosine, either based on a biallelic genetic disruption of the Adk gene, or based on the introduction of a lentiviral vector expressing an inhibitory micro-Differential Effects of the Inflammogen, Lipopolysaccharide, RNA directed against Adk. Infrahippocampal implants of neural proon Animals With a Partial Deletion of the GDNF Receptor, genitor (NP) cells derived from either human or mouse embryonic GFR␣1, Gene stem cells (ESCs) form dense grafts within the infrahippocampal fissure and differentiate into neurons within the CA1 region. Infrahippo-H. A. Boger,* K. Reinert,* C. Umphlet,* and A.-C. Granholm* † campal implants of ADK-deficient mouse ESC-derived NPs robustly suppressed kindling epileptogenesis in the rat. Most importantly, when *Department of Neurosciences, Medical University transplanted into the infrahippocampal fissure of mice 24 h after the of South Carolina, Charleston, SC, USA intra-amygdaloid injection of kainic acid, the same cells significantly †Center on Aging, Medical University of South Carolina, reduced astrogliosis, normalized the expression levels of endogenous Charleston, SC, USA ADK, and completely prevented the emergence of spontaneous recurrent seizures 3 weeks after kainic acid injection. This is a time point at which recipients of wild-type cells or of a sham injection displayed Previous studies have demonstrated that in order for glial cell linederived neurotrophic factor (GDNF) to exert its dopaminergic (DAer-prominent astrogliosis, overexpression of ADK, and recurrent seizures at a rate of more than four seizures per hour. In a first step to develop gic) neuroprotective effects, the GDNF receptor, GFRα1, is required in combination with rearranged during transfection (RET) receptor ty-personalized stem cell therapies for epilepsy, human mesenchymal stem cells with a knockdown of ADK were shown to suppress acute rosine kinase. Inflammation is thought to contribute to the supply of hippocampal injury as well as the development of spontaneous sei-and infiltrating macrophages contribute directly to this process. Adult adherent stem cells are known to have immunomodulatory capabili-zures. In a complementary approach, adeno-associated virus (AAV)based vectors have been engineered to modify ADK expression in a ties, but their potential to ameliorate this detrimental process has not been investigated. We have developed an in vitro model in which adult cell type-selective manner. Overexpression of ADK in astrocytes of the hippocampus of mice was shown to trigger spontaneous seizures, rat dorsal root ganglion (DRG) axons are confronted with a gradient of increasing inhibitory proteoglycan and decreasing laminin. Growth whereas the knockdown of ADK-mediated by antisense expression of an Adk cDNA-effectively suppressed seizures in adenosine-defi-cones in this environment develop a characteristic dystrophic morphology and, when contacted by activated macrophages, undergo dramatic cient mice. Our findings suggest that stem cell-or gene therapy-based focal adenosine augmentation is a rational and efficient approach to axonal dieback. In this study, we sought to determine if culturing DRG neurons with rat multipotent adult progenitor cells (MAPC) or MAPC-suppress seizures in epilepsy and possibly to prevent epileptogenesis.
Supported by grants from the NINDS and the Legacy Foundations. conditioned media (MAPC-CM) could prevent macrophage-mediated axonal dieback. In the presence of MAPC or MAPC-CM dystrophic axons became remarkably active. Macrophages contacted these axons Intracranial Injection of Tau-5 Antibody Reduces Histological extensively, but axonal retraction was prevented. We found that MAPC Tau Deposits in Middle-Aged Tg4510 Mice significantly decreased matrix metalloproteinase-9 release from macrophages, effectively preventing induction of axonal dieback. MAPC M. Brownlow,* † M.-L. Selenica,* † D. Lee, ‡ M. Gordon,* † also induced a shift in macrophages from an M1, or "classically actiand D. Morgan* † vated" proinflammatory state, to an M2, or "alternatively activated" anti-inflammatory state. We extended these findings to human MAPC, or MultiStem, and determined that these cells were also able to pre-*Byrd Alzheimer's Institute, University of South Florida College vent macrophage-mediated axonal dieback. hibited a significant increase in outgrowth over control media and conditions after 24 h. We sought to determine if MAPC could prevent In the last decade, immunotherapies targeting amyloid beta pepaxonal dieback or promote regrowth of injured axons in vivo in a tides have been widely tested in both animal models and clinical trials. dorsal column crush model of spinal cord injury. We transplanted A more recent immunotherapeutic approach is to target tau protein MAPC into the spinal cord immediately following injury, and meainstead, another major feature of Alzheimer's disease (AD). We invessured axonal position at 2, 4, and 7 days postinjury. The transplanted tigated the effects of intracranial injections of 2 µg of tau-5 antibody cells integrated into the lesioned tissue and associated with the endings (against the mid-domain of the tau peptide) into one hippocampus and of injured axons. Four days postlesion, MAPC-transplanted animals 2 µg of a green fluorescent protein (GFP) antibody (both murine IgG1) demonstrated a significant attenuation of axonal dieback normally obin the contralateral side in 13.5-month-old Tg4510 mice (n = 6 per served at this time. Seven days postlesion, MAPC-transplanted anigroup). The GFP antibody does not stain normal mouse brain proteins mals showed a significant increase in the extent of axon extension into when used in immunostaining reactions. Tissue was collected 4 days the lesion core compared to vehicle controls. Our results demonstrate later and sections were stained for several markers of tau deposition that MAPC have therapeutic benefits after spinal cord injury and pro-[anti-phospho-Ser199/202; anti-phospho-Ser396; H150 against total vide evidence that these cells exert positive immunomodulatory and tau (aa 1-150); all rabbit polyclonal antibodies; or Gallyas silver stainneurotrophic influences. We are currently examining the effects of ing against deposited fibrillar tau]. In addition, we examined staining MultiStem in a contusive injury model, which will allow for long-term for microglia (Iba-1) and neurodegeneration (Nissl). Sections were anbehavioral analysis and accelerate the translation of MultiStem into alyzed for reaction product area using a digital scanning microscope clinic for treatment of spinal cord injury. (Mirax). The results indicated that staining for anti-phospho-Ser 199/ 202 and Gallyas was significantly reduced 50-65% by tau-5 injection, compared with GFP-injected hippocampi. A nonsignificant trend for
The Blood-Brain Barrier (BBB) and Angiogenesis reduction was found with immunostaining by antisera directed against as Therapeutic Targets in the Treatment phospho-Ser396. However, no differences between GFP-injected and of Parkinson's Disease (PD) tau-5-injected hemispheres were discerned for total tau staining or microglial activation, nor was there any indication of neurotoxicity (both P. M. Carvey, A. Patel, G. Toia, and B. Hendey by measurement of Nissl sections and visual evaluation of the tissue). These initial data suggest that the tau-5 antibody stimulated clearance of phosphorylated tau deposits, but not total tau staining, and that the Department of Pharmacology, Rush University, Chicago, IL, USA mechanism of clearance did not require activation of microglia or death of neurons.
The endothelium of the neurovasculature is a dynamic structure Research supported by AG18478.
that separates the periphery from the CNS. Harvard Medical School, Belmont, MA, USA angiogenesis (increased expression of integrin β3), colocalized with FITC-albumin leakage, we examined αvβ3 expression in PD patients.
Human pluripotent stem cells are a potential source of cell therapy The PD patients exhibited significant increases in αvβ3 relative to for Parkinson's disease (PD) patients or to examine neurodegenerative aged-matched controls, indicating that angiogenesis is ongoing at the processes. However, therapeutically relevant ventral midbrain (VM) time of death in the substantia nigra pars compacta (SNpc) and putadopaminergic (DA) neurons are not generated by standard differentiamen. Because newly created vessels are unlikely to have developed a tion protocols. We present a new approach that generates a practical BBB and chronic exposure to angiogenic factors can produce vessels yield of human VM DA neurons from human embryonic stem (ES) that are outright leaky, these results are consistent with a dysfunctional cells or induced pluripotent stem (iPS) cells derived from PD patients. BBB. To determine if angiogenesis is instrumental in BBB dysfunc-Importantly, these human VM DA neurons express the transcription tion, inflammation, and DA neuron loss, we posttreated MPTP-treated factor forkhead box protein 2 (FOXA2), confirming the ventral midmice with a cyRGDfV peptide that binds to αvβ3 and prevents angiobrain phenotype. Next we show that human DA neurons integrate and genesis. cyRGDfV prevented the FITC-albumin leakage, changes in function in a rodent model of PD. Finally, we show that flow cytomemicroglia, and the DA neuron loss normally produced by MPTP, sugtry can purify human ES/iPS cell-derived neurons that survive transgesting that other antiangiogenic drugs currently used to treat tumors plantation and function in the dopamine-denervated rat striatum withmay slow PD progression. It is also known that tight junction integrity out forming tumors. In summary, these data provide compelling can be increased using a number of drugs (e.g., caffeine and other evidence for translational studies in our robust primate model of idiophosphodiesterase inhibitors) and may reverse barrier compromise. pathic PD. Towards this goal, we are generating and differentiating Taken together, these data argue that BBB dysfunction may contribute primate iPS cells to test the function of isogeneic and allogeneic neuto PD progression, and therapies designed to prevent angiogenesis or ronal transplantation. enhance tight junctions may slow disease progression.
Supported by the Kenneth Douglass Foundation and NINDS R01-N5052414. of South Carolina, Charleston, SC, USA coupled processes. Endothelial cells, together with astrocytes and peri- §Department of Psychology, University of British Columbia, cytes, form the blood-brain barrier, and they are certainly involved in cerebrovascular events, such as stroke, in which the neurovascular unit Vancouver, BC, Canada is disrupted. Transplantation of neural stem cells (NSCs) within this environment can affect angiogenesis, but conversely, angiogenesis can Deficits in cognitive flexibility are early and debilitating symptoms also affect the fate of NSCs. To develop a better therapeutic use of of neurodegenerative diseases, including Parkinson's disease (PD). NSCs, we therefore investigated how human umbilical vein endothe-Modern theories posit a pivotal role for the locus coeruleus (LC) norlial cells (HUVEC) influence the differentiation of a clinical-grade huepinephrine (NE) system in mediating attention and cognitive flexibilman NSC line (STROC05) in a transwell culture system. Soluble facity. The Adaptive Gain Theory (Aston-Jones and Cohen, 2005), detors increased glial fibrillary acidic protein (GFAP) expression in rived from unit recordings in behaving animals and neural network differentiated NSCs, but also maintained the expression of nestin at modeling, proposes that low levels of tonic LC impulse activity with the level of undifferentiated cells. These changes were the result of concurrent task-related phasic activation facilitates focused attention the emergence of a subpopulation of cells coexpressing nestin and and execution of task decisions to maximize utility in the task at hand. GFAP. These nestin/GFAP double-labeled cells may represent reactive However, when behavioral utility wanes (reward decreases) phasic LC astrocytes present in the glial scar surrounding stroke damage. To deactivation declines and tonic (baseline) LC activity increases. The entermine the contact-mediated effects of endothelial cells, as would be suing tonic mode of LC activity is proposed to disengage behavioral the case within the intact neurovascular unit, human endothelial cells focus from the current strategy or goal and increase cognitive flexibil-(HUVEC and brain) were cocultured with green fluorescent protein ity to permit identification of a new, more remunerative goal in the expression hNSCs. These studies will potentially provide evidence as current context. The ability to focus attention on a goal, but to also to how the neurovascular microenvironment can influence the fate of perform flexibly and find a new goal when the context changes, is a NSCs and indicate particular sites of injection to target-specific mechkey element in high-level cognitive function and adaptive behavior. anisms of repair.
Optogenetic Stimulation of Locus Coeruleus Norepinephrine Neurons in Rats Performing Set-Shifting Tasks: Modulation of Cognitive Flexibility Distinguishing Contact-Mediated Effects From Soluble Factors of Human Endothelial Cells on the Differentiation
LC NE neurons degenerate early in PD. However, the possible role of the LC NE system in these and other cognitive deficits of PD has not been examined. The role proposed for the LC NE system in regulating this flexibility dimension can be tested in animals using set-shifting tasks. We have developed cell type-specific optogenetic techniques to selectively stimulate LC NE neurons with high temporal precision in anesthetized and behaving rats (see Vazey et al., this meeting). We expressed the light-sensitive cation channel channelrhodopsin-2 (ChR2) Stroke is one of the leading causes of death and long-term disability in the world. There are no effective treatments targeting the resid-in LC NE neurons in order to photostimulate these cells phasically or tonically in Long-Evans rats performing an automated, operant cham-ual anatomical and behavioral deficits resulting from stroke. It is known that after stroke the brain undergoes limited self-repair to com-ber-based attentional set-shifting task. We hypothesize that tonic stimulation on trials immediately following a rule change (extradimensio-pensate for the lost structures. Changes in reorganization or neuroplasticity are thought to underlie the partial spontaneous functional recov-nal set-shift, EDS) will decrease perseverative errors and trials to criterion (TTC) for the new contingency, whereas such stimulation ery that often occurs over time following stroke. To understand this innate functional repair process, it is necessary to improve our compre-when the animal is approaching criterion will increase TTC. Conversely, phasic stimulation aligned with the original contingency but hension of the mechanisms mediating stem cell functional recovery in stroke-damaged brain tissues. This understanding will help move for-applied immediately following an EDS should increase perseverative errors and TTC, but decrease TTC when the animal is approaching ward the field of cell transplantation, a promising therapeutic strategy for brain repair. It has been shown that the transplantation of stem cell criterion. Results of these studies will reveal the role of the LC NE system in cognitive flexibility and associated deficits in PD, and facili-progeny from multiple sources ameliorates motor deficits after stroke. immunosuppressed rats were transplanted with NSCs (2 × 10 5 ) into the ischemic boundary zone in the striatum. Animals were tested biweekly Nervous system development relies on a network of transcriptional for the use of their forelimbs in the cylinder test and for locomotor repressors and activators to control the orderly acquisition and mainteactivity. After 12 weeks' survival time, the animals were perfused and nance of neural cell fate. A potential key regulator in this network is brains were processed for histopathology and immunocytochemistry. the RE1-silencing transcription factor, REST, which represses a large Grafted NSCs, identified with a human-specific nuclear marker surnumber of neuronal genes. During development, the REST repressor vived in the stroke-damaged peri-infarct tissue, expressed the ChR2 complex plays important roles in mediating repression and chromatin transgene and extended neurites into the host parenchyma. Our behavplasticity in pluripotent embryonic stem (ES) cells and multipotent ioral analysis demonstrated that light stimulation of animals grafted neural stem/progenitor (NS/P) cells. REST is highly expressed in ES with the ChR2 optogenetically engineered NSCs increased their forecells, and downregulated to minimal levels in NS/P cells. As NS/P limb use in comparison to vehicle-treated animals. In addition, animals cells differentiate along the different neural lineages, REST remains that received the ChR2-expressing NSCs increased their motor activity present in glia but absent in neurons, allowing restricted expression of and total distance covered during light stimulation relative to vehicleneuronal genes exclusively in neurons. However, why REST is regutreated animals subjected to light stimulation. Our data suggested that lated differentially at different stages of neural development remains excitatory influences of grafted neural stem cells may offer benefit in unknown. To understand the importance of the differential regulation experimental stroke. of REST, we manipulated REST expression using gain-and loss-offunction approaches in vivo and in vitro. We found that while ES cells maintained their pluripotency in the absence of REST and are able to Biodistribution of Human Umbilical Cord Blood Cells in Infused generate the three germ layers, ES cell-converted as well as primary PSAPP Mice NS/P cells had reduced capacity to form neurospheres and self-renew. Upon withdrawal of growth factors and differentiation, we found a significant increase in the number and maturation of neurons and aber-D. Recent work from our laboratories on developing cell transplantation-based therapies for spinal cord injury (SCI) has demonstrated the marrow of HUCBC CD45 + cells were determined 24 and 72 h after transplantation by PCR and flow cytometry. We determined the pres-benefits of utilizing predifferentiated astrocytic progeny of precursor cells over the use of multipotent precursors to promote repair. We ence of positive cells in bone marrow (BM) and blood through flow cytometry. Immunohistochemistry determined distribution of HUCBC have compared the effects of transplanting undifferentiated glial precursors and two distinct astrocytic populations that can be derived CD45 + cells. HUCBC CD45 + cells mainly home into recipient mice bone marrow, not peripheral blood. Both PSAPP1 + and PSAPP1 − re-from the same precursor population by application of different proastrocytic inducers. Transplantation of glial precursor-derived astro-cipient mice had more HUCBC CD45 + cells in the 24-h time point (TP) than those at 72 h (PSAPP1 + 24 h, 3.7%; 72 h, 0.67% and cytes (GDA) generated using bone morphogenetic protein 4 (GDAs BMP ) promoted robust functional recovery. Treatment of injury sites with PSAPP1 − 24 h, 2.1%; 72 h, 1.6%). We report that while PSAPP1 + mice had more positive HUCBC CD45 cells at 24 h than PSAPP1 − the undifferentiated glial precursors, or a second type of astrocyte derived from the precursor population by induction with ciliary neuro-recipients, at the 72-h TP, PSAPP1 − had more HUCBC CD45 + than their PSAPP1 + counterparts. Positive HUCBC CD45 cells survive in trophic factor (GDAs CNTF ), however, failed to promote locomotor recovery. As a first step towards translating the therapeutic benefits bone marrow even after 72 h of transplantation in PSAPP mice.
obtained with transplants of rodent GDAs BMP to use in humans, we have now successfully generated human GDAs BMP and GDAs CNTF from fetal cells, and have found that our previous studies with rodent GDAs Lateral Fluid Percussion Injury of the Brain Induces CCL20
were highly predictive of outcomes with human GDAs. Transplanta- In this report, we used a rat lateral fluid percussion impact (LFPI)
Inflammatory Chemokine Expression in Rats
We have previously reported that the AF5 neural progenitor cell model of TBI to characterize neurodegeneration, apoptosis, and alterline, normal neural progenitor cells, and A2B5 + progenitor cells show ations in proinflammatory mediators at two time points within the secdecreases in cyclin A2 expression in response to cocaine, as well as ondary injury phase. Histological analysis of neurodegeneration by inhibition of cell proliferation. In contrast, cyclin A2 is not changed Fluoro-Jade staining showed mild injury in the cerebral cortex, hippoin mature neurons and microglia, and is increased in astrocytes in recampus, and thalamus. Terminal deoxynucleotidyl transferase dUTP sponse to cocaine (Lee et al., 2008). The purpose of the present study nick end labeling (TUNEL) staining confirmed the presence of apoptowas to further explore the effects of cocaine on proliferation of immortic cells and CD11b + microglia, indicating initiation of an inflammatalized neural progenitor cell lines in comparison to human tumor cell tory reaction leading to secondary damage in these areas. Analysis of lines. A series of tumor cell lines and immortalized neural progenitor spleen mRNA by PCR microarray of an inflammation panel led to cells was tested for changes in cell proliferation in response to cocaine the identification of CCL20 (also known as macrophage inflammatory and related drugs. All cell lines tested showed inhibition of cell prolifprotein 3) as an important proinflammatory signal upregulated 24 h eration at 100 µm. Smaller doses differentially affected the various after TBI. Although CCL20 expression was observed in spleen and cell lines. AF5 cells showed the strongest inhibitory effect of cocaine, thymus after 24 h of TBI, it was not expressed in degenerating cortex with a decrease in cell proliferation of approximately 30% at 1 µm or hippocampal neurons until 48 h after insult. These results demon-(p < 0.001), a dose that can be achieved in cocaine-abusing human strate that the systemic inflammatory reaction to TBI starts earlier than subjects. Three other immortalized neural progenitor cell lines were the local brain response and suggest that spleen-and/ or thymus-derived tested. C17.2 showed an inhibition of approximately 11% at 1 µm CCL20 might play a role in promoting neuronal injury and CNS in-(p < 0.05), while REN-CX and RTC2 cells did not respond to 1 µm flammation in response to mild TBI. cocaine. Of the tumor cell lines, DAOY and MCIDX medulloblastoma cells were least responsive to cocaine, showing no response to 1-10 µm cocaine, while D283 and SH-SY5Y were most responsive, show-What Can Go Wrong During Convection Enhanced Delivery Into the Putamen Nucleus? ing significant inhibition of proliferation at 1 µm. A number of local anesthetics and dopamine uptake inhibitors were tested for inhibition of proliferation. Procaine, benzocaine, bupivicaine, and lidocaine had M. E. Emborg,* † M. Brady, ‡ R. Raghavan, ‡ J. Raschke,* no effect on cell proliferation. The dopamine transporter inhibitors K. Brunner,* N. Goecks,* R. Velotta,* K. Sillay, § C. Ross, ¶ GA2-50 and 4,4 diCl BZTP also did not affect cell proliferation, but R. Fisher,# K. Kubota,** and A. Alexander †# † † were toxic at high doses (100 µm). Studies of the expression of cytochrome P450 isoforms CYP3A4, CYP3A5, CYP3A7, and CYP3A43 *Preclinical Parkinson's Research Program, Wisconsin National are currently in progress, but have not revealed any apparent relation-Primate Research Center, University of Wisconsin-Madison, ship between cytochrome P450 expression and the proliferative re-Madison, WI, USA sponse to cocaine. Studies on the relationship between the effect of †Department of Medical Physics, University of Wisconsin-Madison, cocaine on cell proliferation and generation of reactive oxygen species Madison, WI, USA are currently in progress.
Research pension to the desired area becomes essential for patient safety. In that §Center of Excellence for Aging and Brain Repair, Department regard, CED is also hypothesized to produce a more predictable and of Neurosurgery and Brain Repair, University of South Florida even pattern of distribution. In this study, we decided to challenge this College of Medicine, Tampa, FL, USA last concept and analyze: a) the maximal volume of infusate that remains in the desired area, b) the pattern of distribution beyond the Many neurodegenerative diseases are known to be associated with putamen boundaries, c) the volume of infusion versus volume of districhronic inflammation. There exists a growing body of evidence sugbution versus gadoteridol concentration, and d) the potential areas of gesting that innate immunity is pathologically unregulated in various leakage during the infusion procedure. Twenty-five adult macaque neurodegenerative diseases, such as Alzheimer's disease (AD). In monkeys received bilateral intraputaminal infusions of a 100 µl infuthese disease states, the activation of microglia releases proinflammasion of the MR contrast agent gadoteridol (ProHance, Bracco Diagnostory cytokines, such as tumor necrosis factor-α (TNF-α), which have tics; 2 mM/L) and bromophenol blue (0.16 mg/ml), coinfused in a been implicated in causing neuronal cell death. The immune-suppresssaline solution. Brain targeting to the postcommisural ventral putamen ing properties of both nicotine and ∆9-tetrahydrocannabinol (∆9-THC) nucleus was achieved using intraoperative magnetic resonance imhave been well documented, but no previous studies have investigated aging (MRI) intracerebral navigation combined with an adaptable, their combined effects on the innate immune system function. In repivot point-based system (Emborg et al., 2010). Infusions were percent studies, we have discovered that nicotinic receptors are functionformed using an endport step catheter (0.64 mm OD) with or without ally expressed on microglia and that nicotine reduces microglial actia stylet and a pressure monitoring and infusion pump controller system vation and enhances microglial uptake of amyloid beta 1-42 (Aβ 1-42 ), a (Engineering Resources Group Inc.) in combination with a MRI-compatpeptide implicated in AD. The cannabinoid receptor, CB2, is also presible infusion pump (Harvard Apparatus). MRI (T1, angiographies and ent on microglia and stimulation has been shown to result in reducdiffusion tensor imaging) was performed in a 3T GE scanner. Additions in proinflammatory cytokine production and alterations in microtional studies were performed in gels and ex vivo brains. Our results glial phenotype. Here we report findings from a lipopolysaccharide include: 1) at most 30 µl can be infused into a single location in the (LPS) mouse model and Alzheimer double transgenic PSAPP mice macaque putamen before infusate begins to spread beyond the puta-(expressing specific presenilin and amyloid precursor protein mutamenal boundary, 2) distribution beyond the putamen boundaries diftions) that were injected (IP) with a combination of nicotine and ∆9fers between white and gray matter due to different tissue expansion THC. Treatment with these compounds result in reductions in microgand defines the flow of infusate in the region, 3) during insertion, lial activation observed through expression of CD45, as well as reducleakage is observed in catheters without a stylet, as the catheters get tions in Aβ levels. Greater reductions in proinflammatory cytokines occluded and the fluid inside the catheter is displaced by tissue, 4) [TNF-α, interleukin (IL)-6] were also observed after treatment with leakage of fluid in the catheter tract was observed after the extraction nicotine and ∆9-THC. These findings suggest that the combination of of the catheter 10 min after the infusion was completed, 5) if backflow ∆9-THC and nicotine clinically should have greater efficacy in reducfrom within the gray matter of the putamen reaches the dorsal bounding neuroinflammation with less side effects than either drug given ary, infusate easily spreads into the surrounding corona radiata, and 6) alone.
blood vessels adjacent to a catheter's backflow region can redirect infusate to follow the vessel path. The use of a stylet, applying angiography data when planning infusions, monitoring in vivo infusions, and matching the volume of infusate to volume of target structure are possible methods to minimize leakage and maximize predictability. These results in nonhuman primates provide insight into the role that geometry and architecture of the target have to successfully achieving controlled, bounded infusions with CED. free radical-mediated damage such as nitric oxide mediated-toxicity, has been demonstrated by many researchers to have considerable powhereas females are more likely to exhibit caspase-dependent apoptotential as a treatment for a wide range of disorders including stroke, tic cell death. However, not all cell types exhibit the gender differ-Alzheimer's disease (AD), amyotrophic lateral sclerosis, diabetes, and ences because while female dopaminergic and hippocampal neurons hematopoietic disorders based on animal models. However, there are are more resilient, female cerebellar Purkinje cells have no greater some concerns about the ability of hUCBCs to be transplanted safely protection against experimental brain insults. In addition, some forms when they are used clinically due to the potential for rejection and of injury, such as H 2 O 2 , appear to be gender neutral. Cellular therapy graft-versus-host disease (GvHD). Studies in treatments for hematohas considerable potential for a number of disorders, but the role of poietic disorders suggest that the rate of rejection and GvHD is signifigender remains controversial. Mesenchymal stem cells (MSCs) from cantly less than observed with bone marrow cells, supporting the promales have been shown to release significantly greater quantities of the posal that UCBCs are immune immature. However, delayed engraftment proinflammatory factors tumor necrosis factor (TNF) and interleukinand graft failure are commonly observed in human transplants for the 6 (IL-6) and significantly less of the proangiogenic factor vascular treatment of hematopoietic disorders. Whereas the use of multiple endothelial growth factor (VEGF) than female MSCs. In addition, fetransplants has been advocated to improve the efficacy of the grafting, male cells are less likely to undergo apoptosis in response to hypoxia. when considering their use for the treatment of neurodegenerative dis-This suggests that male MSC transplants may be less beneficial than orders such as stroke and AD, there is accumulating evidence that the female cell transplants and there is evidence of this with respect to cells do not need to engraft or survive long term for the transplanted endothelial progenitor cells and atherosclerosis. Female cells transcells to exert their benefit, suggesting that a lack of engraftment would planted into females (or males) had a significantly greater benefit than not hinder therapeutic outcome. In this presentation we will summarize male cells into males (or females). We are therefore advocating that some of the latest studies, such as a recent clinical study performed in in determining the optimal source and type of transplantable cells for China (Yang et al., J. Transl. Med.; 2010) that showed that 4-5 allogeuse in a cell therapy, much consideration should be given to the gender neic hUCBC transplants in 114 patients for a variety of nonhematopoiof both the donor and the recipient. While many studies are performed etic degenerative disorders, including paraplegia, ataxia, multiple scleonly in males, the results may not translate well to the female popularosis, amyotrophic lateral sclerosis, cerebrovascular diseases and multiple tion. It is tempting to speculate that autologous transplants may have system atrophy, were clinically safe, revealing no severe side effects the most benefit in females whereas an allogenic transplant (of female such as rejection or GvHD with up to 4 years follow-up. No informacells) maybe better in males. Further studies are required to determine tion on the efficacy of the cells in the treatment of the disorders was which disorders are affected by gender-specific transplants. Treatreported. No HLA matching or immune suppression were performed ments may need to be tailor made to the gender of the patient. in this study, which would seem to suggest that they are not necessary for this type of treatment. A degree of efficacy and safety for multiple hUCBC transplants was also recently shown in an autologous study of First-in-Human Spinal Cord Neural Stem Cell Transplantation a child with global ischemia, who could no longer be defined as being Trial: Current Status in a permanent vegetative state 6 months after treatment (Jozwiak et al., Cell Med.; 2010). Additional studies with more long-term follow-T. Federici,* K. Johe, † E. Feldman, ‡ J. Glass,* and N. Boulis* up as well as evidence of functional improvement following transplantation are required to fully advocate their use in the clinical setting *Emory University, Atlanta, GA, USA without the need for matching or immunosuppression.
C.V.B. and A.E.W. are consultants for, and P.R.S. is cofounder of, †Neuralstem, Inc., Rockville, MD, USA Saneron-CCEL Therapeutics. Saneron CCEL Therapeutics and Cryo- ‡University of Michigan, Ann Arbor, MI, USA praxis, Cell Praxis are biotech R&D companies researching the therapeutic use of cord blood and other stem cells.
The current abstract describes the status on the first-in-human trial of neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis (ALS). The primary objective of the current trial is to determine the feasibility, safety, and toxicity of direct spinal cord transplantation of human spinal stem cells in patients with ALS. The study was designed to balance risk to subjects with the acquisition of new knowledge regarding direct spinal cord transplantation. We have ABSTRACTS 555 coined the term "risk escalation" to describe the gradual increase in given 30 min after injury. Interestingly, increasing the dose of HOE-140 from 2 mg to 5 mg/kg, IV (either 30 min before or 10 min after risk between cohorts. The trial begins with unilateral transplants (five injections spaced by 4 mm) into the segments of the lumbar cord sup-injury) did not exhibit any neuroprotection. In fact, there was an exacerbation of the tracer's extravasation, edema formation, cell injury, porting proximal limb function in nonambulatory patients (n = 3). The second cohort receives bilateral lumbar transplants (five injections per and nNOS expression. These observations are the first to suggest that bradykinin B2 receptors play an important role in SCI-induced nNOS side spaced by 4 mm, n = 3). The third cohort receives unilateral lumbar injections but are ambulatory, hence bearing the potential to lose expression and spinal cord pathology. An early blockade of bradykinin B2 receptors in the spinal cord following trauma is necessary to induce the ability to walk. The fourth cohort contains ambulatory patients that receive bilateral injections. The fifth cohort receives unilateral cervical neuroprotection. Furthermore, the neurodestructive effects of bradykinin appear to be mediated through mechanisms involving nitric oxide, injections (five grafts at 4 mm intervals from C3 to C5). The final group is ambulatory and receives staged unilateral cervical injections which has not been reported previously. Supported by Swedish Medical Research Council Grant Nr. 2710 followed by bilateral lumbar injections. The FDA has approved the first stage of the trial, which consists of 12 patients. To date, we have (HSS). completed the first and second cohorts (n = 6). Surgeries on the third cohort (ambulatory patients) are ongoing. All patients remain alive. Individuals with Down syndrome (DS) will develop the neuropath-University Hospital, Uppsala University, Uppsala, Sweden ological and cognitive deficits of Alzheimer's disease (AD) by the age of 40. These neuropathological features include microglial activation, Bradykinin is a mediator of the blood-brain barrier (BBB) and beta amyloid plaques, neurofibrillary tangles, and degeneration of both edema formation. However, its role in spinal cord injury (SCI)the basal forebrain cholinergic neurons (BFCNs) and the noradrenergic induced breakdown of the blood-spinal cord barrier (BSCB) and neurons of the locus coeruleus (LC-NE). These degenerative changes edema formation is still not well known. A previous report from our coincide with the onset of severe cognitive impairment beyond that of laboratory shows that bradykinin B2 receptor antagonist (HOE-140, the syndrome itself and include impaired object recognition, working Hoechst, Frankfurt, Germany) in low doses is able to thwart BSCB memory, short-term memory/recall, and visuospatial skills. The first disruption, edema formation, and cell injury in a rat model of SCI. sign of impairment is characterized by an early and progressive loss However, the mechanisms of HOE-140-induced neuroprotection in of LC-NE neurons. We have recently shown that by lesioning the LC SCI are unclear. Recent studies suggest that bradykinin may stimulate in young, healthy DS mice we are capable of reproducing an early endothelial nitric oxide synthase (eNOS) through B1 receptor-medi-AD-like pathology that includes degeneration of BFCNs, increased ated events. However, the role of B2 receptors in NOS upregulation microglial activation, elevated interleukin (IL)-1β mRNA levels in the is not known. Thus, in the present investigation we sought to deterhippocampus, and deficits in cognition. While this pinpoints LC demine whether bradykinin B2 receptor is somehow involved in SCIgeneration as a starting point for propelling degenerative changes, the induced neuronal NOS (nNOS) activation. We used HOE-140, a spefunctionality of the LC has not been implicated. In an attempt to show cific B2 receptor antagonist, at a lower dose to ascertain the role of a proof of principle while introducing a novel methodology in our bradykinin in spinal cord trauma-induced alterations in nNOS expresmouse model of DS, the Ts65Dn, we used designer receptors exclusion, BSCB permeability, spinal cord blood flow (SCBF), edema forsively activated by a designer drug (DREADDs) to directly stimulate mation, and cell changes in our rat model. Note that HOE-140 at the LC neurons at a time when the neurons have just started to degenhigher doses may have some B2 receptor agonistic activity as well.
Characterizing the Role of the Locus Coeruleus in Modulating Cognitive Deficits in Neuropathology and Down Syndrome: Neuroprotective Effects of Bradykinin B2 Receptor Antagonist Novel Application of Designer Receptors Exclusively Activated HOE-140 in Spinal Cord Injury Are Mediated Through Nitric by a Designer Drug (DREADDS) Oxide-Related Mechanisms
erate. DREADDs target a specific promoter sequence via local viral SCI was produced in equithesin-anesthetized animals by making a londelivery to target a select population of neurons, which allows for the gitudinal incision into the right dorsal horn at the T10-11 segment.
transduction of a mutated acetylcholine (mACh) receptor that responds The animals were allowed to survive for 5 h after the injury. A focal to the inert compound clozapine-N-oxide (CNO). The effects of CNO trauma to the rat spinal cord significantly increased the BSCB permeare acute and allow for temporal control; here they will be used to ability to Evans blue, [ 131 I]sodium in the five spinal cord segments turn the LC "on" then "off" in aged (12 months old) Ts65Dn mice. examined (e.g., C4, T5, T9, T10-11, and T12). These spinal cord seg-We propose that turning on the LC in aged Ts65Dn animals will rements also showed marked upregulation of nNOS activity and exhibverse cognitive impairment in the novel object recognition task. We ited profound reduction in the SCBF (mean −30%). Measurement of also propose that long-term delivery of CNO will not only enhance spinal cord water content showed a significant increase in all the above cognition but will also reverse the degenerative changes observed in spinal cord segments. Profound nerve cell, glial cell, and myelin damnormal aging in DS as a result of increased LC-NE. These are the first age was seen in these spinal cord segments that are most pronounced studies of this kind to be evaluated in a mouse model of DS and therearound the vicinity of the lesion site. A close correlation between fore are a novel approach to understanding the mechanism by which upregulation of nNOS and cell injury was clearly seen after SCI. Exneuropathology and cognitive decline develop in DS individuals. travasation of lanthanum was largely present within the endothelial Supported by NIH grant AG012122. cell cytoplasm and also found occasionally in the basal lamina. Pretreatment with lower doses of B2 receptor antagonist HOE-140 (0.1 mg to 1 mg/kg, IV) 30 min prior to trauma significantly attenuated spinal cord pathology and upregulation of nNOS expression. The SCBF showed marked improvement in this group. This effect of HOE-140 was also seen when the compound was administered 10-15 min after SCI, but no neuroprotection was seen when the compound was 556 ABSTRACTS
Long-Term Treatment With a High-Fat/High-Cholesterol Diet
bral cortex, hippocampus, striatum, and cerebellum of Naglu mice via electron microscopy (EM). BBB functional integrity was further inves-in Young and Aged Rats: Inflammatory Response, Blood-Brain Barrier Breakdown, and Cognitive Impairment tigated by tests for vascular leakage with Evans blue (EB) and albumin. EB dye was intravenously injected into Naglu mice at early, late, or end stage disease. Wild-type mice (controls) were also injected at L. Freeman* and A.-C. Granholm* † the same ages. After 30 min, mice were euthanatized and the brains examined for EB leakage. Immunohistochemical staining for albumin *Department of Neurosciences, Medical University of South was also performed in serial brain sections. Also, immunohistochemi-Carolina, Charleston, SC, USA cal staining for GM3 ganglioside was performed to detect this second- †Center on Aging, Medical University of South Carolina, ary storage product in the brains of Naglu mice. Major findings of our Charleston, SC, USA study were: 1) capillary ultrastructure revealed endothelial cell damage and astrocyte degeneration, which compromised the BBB, resulting in Consumption of mainly saturated fats and cholesterol in the diet vascular leakage; 2) endothelial cells showed endoplasmic reticulum has been proven to be damaging to organs such as the heart and liver, swelling and formation of numerous large cytoplasmic vacuoles, departicularly through inflammatory mechanisms. However, the effects generation of cytoplasmic organelles, abnormal microvilli formation, of a high saturated fat and cholesterol diet (HFHC diet) on the brain and shedding of fragments of cell membrane and microvilli; 3) edemaare not currently well understood. We hypothesize that long-term treattous space around microvessels; 4) pericyte degeneration was observed ment with this type of diet may be damaging to the brain, especially in the large majority of damaged vessels, 5) highly vacuolated perivasthe hippocampus, a vulnerable region to ischemia and hypoxia. We cular macrophages were found in contact with microvessels; 6) a mialso hypothesize that aged subjects exhibit an enhanced response to croaneurysm was noted adjacent to a ruptured endothelium; 7) EB and this diet compared to young subjects due to increased inflammation albumin microvascular leakage was clearly indicated in multiple brain and ensuing alterations to the blood-brain barrier (BBB) permeability.
structures; 8) GM3 ganglioside accumulation was determined in brain Previous work from our laboratory demonstrated that a 10% hydrogemicrovasculature endothelium. These new findings of BBB structural nated coconut oil and 2% cholesterol diet (HFHC diet) resulted in and function impairment in MPS III B mice even at early disease stage impaired performance on the 12-day water radial arm maze, increased may have implications for disease pathogenesis and should be considcirculating cholesterol and triglyceride levels, increased microgliosis, ered in current and future development of treatments for MPS III B. and decreased dendritic microtubule associated protein 2 (MAP2) Special attention should be given to the possibilities for cerebral hemstaining in the hippocampus after only 8 weeks on the diet. Our current orrhages in MPS III B. study has further evaluated long-term effects of the HFHC diet on Supported by The Children's Medical Research Foundation. cognition and hippocampal morphology using the same HFHC diet for 6 months starting at the age of 4 months (young) or 14 months (aged) in male Fischer 344 rats. In this long-term study, serum was collected Behavioral and Histological Analysis of a Partial Double Lesion in order to analyze triglyceride and cholesterol levels, water radial arm Model of MSA-P maze behavior was performed, and immunofluorescence studies on the hippocampus have been conducted. These experiments revealed J. García,* † C. Kaindlstorfer, ‡ M. Döbrössy, † C. Winkler,* impaired working and reference memory, a compromised BBB, in-G. Wenning, ‡ and G. Nikkhah † creased microgliosis, and dendritic damage in HFHC-treated rats compared to control rats. Alterations in cognitive and morphological mea-*Department of Neurology, University Hospital Freiburg, sures were exacerbated in aged versus young rats, suggesting enhanced sensitivity to this diet with aging. Together, these results provide novel Freiburg, Germany evidence for a role of inflammation in diet-induced neurodegeneration. Animals received baseline training on the staircase and the corridor tests, and were additionally tested on the stepping, the cylinder, and In Sanfilippo syndrome type B (MPS III B), a deficiency of alpha-N-acetylglucosaminidase (Naglu) enzyme leads to accumulation of he-the drug-induced rotation on multiple occasions following lesion surgery. Under the surgical and testing paradigms used, the behavioral paran sulfate (HS), a glycosaminoglycan (GAG), within cells and to eventual progressive cerebral and systemic organ abnormalities. How-data show robust lateralized deficits on all tasks, albeit the partial 6-OHDA and the double-lesioned animals were most impaired. Interest-ever, little is known about the competence of the blood-brain barrier (BBB) in MPS III B. BBB dysfunction in this devastating disorder ingly, the double lesion had an accumulative effect on the corridor test, partially on the staircase test, and altered deficit profile compared could contribute to neuropathological disease manifestations. The aim of this study was to determine structural and functional integrity of to the two other lesion groups on the rotation and the staircase tests. Histological analysis confirmed the ϳ40% dopamine loss from the the BBB in a mouse model of Sanfilippo type B at different stages of disease. The primary focus was analyzing BBB competence in various striatum (6-OHDA and double lesion animals), as well as the similar loss of striatal neurones (QA and double lesion animals). In summary, brain structures known to experience neuropathological changes. BBB structural characteristics were examined in microvessels from the cere-the study generated the behavioral deficit profile of a partial double lesion rat model mimicking an early stage of MSA-P. Using this plat- Neural transplantation into appropriate target regions within the brain of Neurosurgery and Brain Repair, University of South Florida is one promising approach to overcome this problem. The goal is to College of Medicine, Tampa, FL, USA achieve long-term anticonvulsant effects and functional repair of brain regions via modulation of the epileptic network. In our previous trans- †James A. Haley VAMC, Tampa, FL, USA plantation studies using a rat model of temporal lobe epilepsy, we ‡Department of Molecular Pharmacology and Physiology, grafted different γ-aminobutyric acid (GABA)-producing cell types University of South Florida College of Medicine, Tampa, FL, USA mainly into the substantia nigra pars reticulata (SNr), a basal ganglia §USF Health Byrd Alzheimer's Institute, University of South Florida structure known to be involved in the propagation and manipulation College of Medicine, Tampa, FL, USA of different seizure types emanating from the limbic system. The dif- ¶Sanders Brown Center on Aging, Lexington, KY, USA ferent cell types we used for comparing their anticonvulsant efficacy included rat fetal striatal GABAergic cells and genetically engineered The protective/neurotoxic role of fractalkine (FKN) and its recep-GABA-producing cells from conditionally immortalized mouse cortitor CX3C chemokine receptor 1 (CX3CR1) signaling in neurodegenercal neurons and from rat striatal neurons, respectively. All GABAative disease is an intricate and highly debated research topic. It appears producing cell types showed clear but transient anticonvulsant effects that the FKN/CX3CR1 axis plays a direct role in neurodegeneration and/ after grafting (cf., Löscher et al., TINS 31; 2008). Our present studies or neuroprotection, depending upon the CNS insult. However, all studmainly address the following questions: 1) Are specific subregions of ies to date focused on the role of FKN/CX3CR1 signaling in pathologthe SNr or other basal ganglia regions such as the subthalamic nucleus ical conditions, ignoring the relevance of FKN/CX3CR1 signaling un-(STN) more suitable for grafting GABA-producing cells? 2) Which der physiological conditions. In the present study we used CX3CR1 −/− , other cell types will prove advantageous compared to previously used CX3CR1 +/− , and wild-type mice to investigate the physiological role cells regarding long-term anticonvulsant efficacy after transplantation of CX3CR1 receptor in cognition and synaptic plasticity. Threeinto basal ganglia regions? In our present studies we used local micromonth-old CX3CR1 −/− , CX3CR1 +/− , and wild-type mice were exposed injection of the GABA-potentiating antiepileptic drug vigabatrin as a to contextual fear conditioning and Morris hidden platform water strategy to identify optimum basal ganglia target regions for neural maze, to test hippocampus-dependent learning. Our results demontransplantation of GABA-producing cells in an acute seizure model strated for the first time that mice lacking CX3CR1 receptor show (see Abstract by Backofen-Wehrhahn et al., this Meeting). With regard contextual fear conditioning and spatial memory deficits. To determine to the cell types, on the one hand we currently use human model neuwhether CX3CR1 deficiency also affects motor learning, all mice were rons (Ntera-2 cells differentiated into a mixed population of mature tested on the accelerated rotarod. Wild-type mice performed signifineurons), which have previously been shown to integrate successfully cantly better on the last day of trial compared to the first day than did into the nervous systems of both experimental animals and human CX3CR1 −/− and CX3CR1 +/− mice, suggesting motor learning deficits in basal ganglia infarct patients without evidence for tumor formation. CX3CR1 −/− and CX3CR1 +/− mice. There were no significant differ-Preliminary data did not reveal robust anticonvulsant efficacy of Nteraences on the first trial of testing between all experimental groups, 2 cells after grafting into the STN. This is in line with previous data which suggests that there is no difference in baseline motor skills. To showing that increased inhibition of the SNr or the STN is necessary investigate whether CX3CR1 deficiency leads to impairment in other to inhibit seizures emanating from the limbic system. The differentiforms of synaptic plasticity we analyzed the induction and mainteated Ntera-2 cells, however, comprise glutamatergic, GABAergic, and nance of long-term potentiation (LTP) in the CA1 region of CX3CR1 other phenotypes. On the other hand, we currently use rat striatal prenull mice (3 months old). Acute hippocampal slices were made from cursor cells pretreated with fibroblast growth factor-2 (FGF-2) and a CX3CR1 −/− , CX3CR1 +/− , and wild-type mice. Our results showed that caspase-1 inhibitor (protocol adapted from Hattiangady et al., Exp. deficiency in CX3CR1 causes a decrease in LTP. Mice lacking Neurol. 212; 2008) and rat neural stem cells from the medial gangli-CX3CR1 receptor have increased levels of interleukin (IL)-1β, so we onic eminence expanded as neurospheres and incubated with FGF-2 asked whether the IL-1 receptor antagonist (IL-1ra), which blocks ILand epidermal growth factor (protocol adapted from Waldau et al., 1 receptor I, might actually reverse the impairment in LTP that we Stem Cells 28; 2010) for grafting into basal ganglia regions. First data observed in the CX3CR1-deficient mice. To determine if IL-1ra can from these transplantation studies will be presented. improve LTP in CX3CR1-deficient mice, hippocampal slices from Supported by a grant (GE1103/7-1) from the German Research CX3CR1 −/− mice were perfused with 100 µg/ml of IL-1ra. We now Foundation (Bonn, Germany). show that blocking the function of IL-1β completely reverses the impairment in LTP. Taken together, our results reveal that, under physiological conditions, disruption in FKN signaling will lead to impairment in cognitive function and synaptic plasticity due to increased levels of IL-1β.
Comparison of Different Cell Sources for Neural Transplantation Into Regions of the Basal Ganglia in Experimental Epilepsy
This work was supported by the National Institutes of Health (AG004418 P.C.B.; AI058256 J.K.H.) and the VA Medical Research Service.
ABSTRACTS

Recovery of Spatial Memory and Hippocampal LTP in Homer1
symptom control than medicine alone, provide a rationale for testing DBS in early PD. Investigators at Vanderbilt are conducting the first
Knockout Mice by Targeted Gene Delivery of Homer1c Via Recombinant Adeno-Associated Virus
randomized investigation of STN DBS in 30 patients with early PD (IDE#G050016). We present here intraoperative MER from the first 11 participants randomized to surgery. Patients in the single-blind, ran-H. Gerstein,* † K. J. O'Riordan, † S. Osting, † and C. Burger † domized, parallel-groups trial must be ages 50-75 with Hoehn & Yahr Stage II idiopathic PD, and on anti-PD medicine less than 4 years *Neuroscience Training Program, University of Wisconsin-Madison, without development of fluctuations. Surgical and MER analysis Madison, WI, USA methods were identical to standard of care for advanced PD. Briefly, †Department of Neurology, University of Wisconsin-Madison, merged CT/MRI and planning software (Waypoint planner, FHC) Madison, WI, USA were used to plan the surgical trajectory and manufacture customized stereotactic miniplatforms (mT Platform, StarFix, FHC). During elec-The Homer family of proteins has been implicated in the structure trode implantation, 10-s MER were made using 0.3-1 MΩ tungsten and function of the postsynaptic density in neurons. Homer1 knockout electrodes at 0.5 mm intervals along the trajectory and then processed (KO) mice show deficits in sensory, social, and motor behavioral and stored in a four-channel Leadpoint recording system (Medtronic). tasks, as well as those testing spatial learning and memory. Previous Root mean square of each trace was calculated (MATLAB, The Mathresearch in our lab implicates one of the long forms of Homer1, Homer1c, Works) and the STN/SN ratio was used to assess background activity. in learning and memory, specifically in cognitive aging. Here we used Single units were extracted via automated cluster analysis (Spike Sorrecombinant adeno-associated virus (rAAV) to deliver Homer1c to the ter 2, Plexon) and visual inspection with template matching, and charhippocampus of Homer1 KO mice (rAAV-Homer1c), in an attempt to acterized (Neuroexplorer 4, Nex Technologies). MER data from the rescue the cognitive impairments found in these animals. We show first 11 patients to receive surgery were included. They are 10 males that hippocampal expression of Homer1c in Homer1 KO mice resultand 1 female, with an average age of 60.0 years (range 50-74) and ing from a high dose of viral vector (1.2 × 10 11 viral genome copies) untreated Unified Parkinson's Disease Rating Scale motor score of improves their performance in the radial arm water maze (RAWM), a 27.0. STN was identified in 98 tracks in 22 hemispheres, across which test of spatial memory. A lower dose of rAAV-Homer1c (2.4 × 10 10 STN background activity was 11.9 ± 0.6 mV. Median firing rate of viral copies) resulted in a trend towards an improvement in perforthe 136 STN units isolated was 25.5 Hz (25-75th percentile; range mance. Although it has not been studied, we hypothesized that hippo-17.9-35.5 Hz). In this small analysis, STN showed both lower overall campal learning impairments seen in Homer1 KO mice reflect deficits activity and firing frequency than the range of 33-42 Hz that is typiin the synaptic properties of these mice. Using two different long-term cally reported in advanced PD. These findings provide evidence that potentiation (LTP) stimulation paradigms in acute hippocampal slices, STN hyperactivity continues to increase with progression of clinical we found that the loss of Homer1 in the hippocampus results in a findings in idiopathic PD, and underscore the importance of applying complete reduction of late-phase LTP upon stimulation with a high potentially neuroprotective therapies that rely on STN activity modulafrequency stimulation (HFS) paradigm, and a significant reduction, but tion as early as possible in the disease course. not total ablation, of both early and late-phase LTP with theta burst
The clinical trial from which this case is presented is supported stimulation (TBS and is an inventor on cord blood pa-impactor (diameter 3 mm) impacted the brain at a velocity of 6.0 m/s, reaching a depth of either 1.0 mm (moderate TBI) or 2.0 mm tents licensed to Saneron CCEL Therapeutics, Inc. (severe TBI) below the dura mater layer and remained in the brain tissue for 150 ms. Postoperatively, animals were randomly assigned to skull bone flap replacement with or without bone wax or no bone
The Role of Noradrenergic Innervation in Neurodegeneration reconstruction. At 5 days post-TBI, animals were euthanized, and brains were harvested and processed for triphenyltetrazolium chloride A.-C. Granholm,* † J. Lockrow,* A. Fortress,* E. Vazey,* (TTC) staining. The replacement of the skull bone with bone wax V. Hinson,* M. Eckert, ‡ and G. Aston-Jones* proved to be aesthetically pleasing and provided normalized gross bone architecture. TTC results, however, revealed that TBI animals *Department of Neurosciences, Medical University of South Carolina, that received skull bone flap with bone wax had much larger cortical Charleston, SC, USA damage than those TBI animals that underwent skull bone replacement †Center on Aging, Medical University of South Carolina, only or no aesthetic maneuver at all. Interestingly, following TBI, es-Charleston, SC, USA pecially when the severe model was performed, we observed brain ‡Department of Otolaryngology, Medical University herniation that would benefit from therapies directed at releasing intracranial pressure (i.e., skull bone removal). Aesthetic repair of the skull of South Carolina, Charleston, SC, USA bone after TBI, while able to reconstruct the general bone structure, may actually exacerbate TBI-induced cortical tissue damage.
Early and progressive degeneration of locus coeruleus noradrenergic (LC-NE) neurons has been reported in patients with both Alzhei-Funding by USF Department of Neurosurgery and Brain Repair Funds.
mer's disease (AD) and Parkinson's disease (PD . In addition to working memory impairment, the DSP-4 lesion increased activation of microglial cells and reduced levels of Systemic treatment of cerebral ischemia with human umbilical brain-derived neurotrophic factor (BDNF) in the hippocampus. Hippocord blood (HUCB) mononuclear cells (MNC) 48 h after middle cerecampal and cholinergic cell loss were exacerbated by the NE neurobral artery occlusion (MCAO) in rats decreases infarct volume, intoxin, suggesting that the NE innervation modality supports survival duces significant recovery of motor function, and decreases the inflamof these neurons, at least during the aging process. In addition, we matory response. HUCB cells decrease spleen size and reduce T-cell have observed that DSP-4 and 6-OHDA lesions have additive effects proliferation after MCAO. The HUCB MNC are composed of heteroon dopaminergic cells, suggesting that LC-NE declines also affect geneous cell populations including T cells, B cells, monocytes, and other signaling systems that are critical for cognitive and motor funcmacrophage and a small population of stem cells. In this study we tion. The current presentation will demonstrate recent clinical and baexamined the effect of different HUCB cell fractions on the cellular sic science work in this field and propose several plausible scenarios profiles of the spleen and blood. Adult *Buck Institute for Research in Aging, Novato, CA, USA The CD14 − HUCB treatment significantly decreased the number of †University of California, Irvine, CA, USA CD4 + macrophages in the spleen while the CD133 − HUCB treatment increased their number compared to the MCAO-only group (p < ‡University of Nevada, Reno, NV, USA 0.001). In the blood, there was a significant decrease in the number of CD4 + macrophages in all groups except the CD133-depleted group Most patients who survive the acute phase of stroke recover at least partially over the ensuing weeks to months. Some of the underly-(p < 0.05). All HUCB treatments decreased the number of CD4 + T cells in the spleen compared to the MCAO-only group (p < 0.05), but ing mechanisms are being identified, including changes in gene expression, altered neuronal excitability, axonal sprouting, synaptogene-had no statistically significant effect on circulating T cells. There were no significant differences between the experimental groups when the sis, somatotopic reorganization, and formation of new cortico-cortical connections. These phenomena, in turn, suggest a variety of therapeu-number of B cells in the spleen or blood was determined. These results suggest that the main population impacted by HUCB cell treatment tic interventions that might help to hasten or enhance clinical recovery, some of which will be discussed by the symposium speakers. David regardless of the composition of the HUCB preparation is the macrophage in the blood and spleen. In addition, all HUCB cell preparations Greenberg will provide an introduction. Justin Hill will describe the role of the glial scar in stroke repair. Ron Frostig will report on sen-decreased the number of CD4 + T cells in the spleen. Further analysis of splenocyte proliferation will be performed. sory stimulation and protection from stroke. Qi Wan will discuss electrical stimulation and brain recovery from stroke. Research supported by James and Esther King Biomedical Re-Patients were symptomatic for ≥ 5 years, Hoehn and Yahr stage 3 to Huntington's disease (HD) is a fatal neurodegenerative disorder, with autosomal dominant inheritance pattern, caused by expression of 4 (H&Y) OFF medication, and had parkinsonian symptoms responsive to oral L-dopa but insufficiently controlled by optimized pharmaco-a mutant form of huntingtin (htt) protein containing an expanded polyglutamine repeat. One possible treatment for HD may be to reduce therapy. Spheramine patients received bilateral implantation (ϳ325,000 cells/side) into the postcommissural putamen, whereas sham surgery the expression of mutant htt in the brain via RNA interference. Unless the therapeutic molecule is designed to be allele specific, both wild-patients received partial burr holes. The primary efficacy endpoint was a change in the Unified Parkinson's Disease Rating Scale (UPDRS) type and mutant protein will be suppressed by an RNA interference treatment. While Htt is required for embryonic development, its nor-Part III (motor) score in the OFF medication state from baseline to 12 months after treatment. Patients were followed for up to 4 years under mal function in the adult brain is unclear. To test the hypothesis that the adult primate brain could tolerate reduced levels of wild-type htt double-blind conditions, until the final patient reached the 12 month follow-up point. The mean changes from baseline in UPDRS motor High Levels of Dopamine Transporter Immunoreactivity in the Reinnervated Putamen of Parkinson's Disease Patients Over a score OFF medication were not significantly different in the Spheramine and sham groups (−10.5 and −10.1, respectively; p = 0.9387). for the reuptake of dopamine after synaptic release. In PD, DAT expression in the striatum is diminished, reflecting the degeneration of Some spinal cord and peripheral nerve injuries cause flaccid paralmidbrain dopaminergic neurons. We show, using immunofluorescence ysis because of motor neuron death. The absence of motor axons to staining, that DAT is robustly expressed in transplanted dopamine neudistal muscles causes immediate skeletal muscle denervation atrophy ron terminals in the reinnervated putamen and caudate, and that DAT and inexcitability for which there is no specific treatment. With time expression is maintained for up to 14 years posttransplantation. In adthis denervation leads to muscle degeneration. One intervention stratdition, the transplanted dopamine neurons show a healthy and nonatroegy to restore muscle innervation is to transplant neurons into nerves phied morphology. Our postmortem examination of tissue from PD connected to denervated muscles (Thomas et al., J. Neurophysiol. 84: patients who have received fetal VM cell transplantation demonstrates 591-595; 2000). This local source of neurons results in muscle reinthat grafted fetal dopaminergic neurons survive for over a decade postnervation, which curtails atrophy and reestablishes muscle excitabliltransplantation without significant signs of neurodegeneration. These ity. However, the muscles are weak mainly because of incomplete findings are encouraging for the development of future fetal and stem reinnervation. Here we test the hypothesis that an exogenous neurocell replacement therapies for PD. trophic supply for transplanted motoneurons provided via cotransplantation of Schwann cells improves motoneuron survival. Cleveland, OH, USA transplantation there was greater cholinergic neuron survival in the NT-3/D15A/p75-2 cotransplants. The presence of local Schwann cells and neurons increased axon growth into the medial gastrocnemius Stem cell transplantation is emerging as a potential therapeutic treatment for autoimmune disorders such as multiple sclerosis (MS). muscle. Experimental muscles were weak compared to muscles of naive control rats despite significant reinnervation and reversal of muscle However, little is known regarding the mechanistic interaction between the diseased tissue environment and transplanted cells. In the fiber atrophy. The increase in the mean myofiber size and muscle excitability introduces the potential to stimulate the transplanted neurons present study, we demonstrate sustained functional benefit in mice with experimental allergic encephalomyelitis (EAE) after IV adminis-electrically to control muscle contractions and to initiate joint movements.
Decade After Transplantation With Fetal Dopamine Neurons
tration Umeå, Sweden compared to controls. Electron microscopic analysis provided evidence of remyelination. Tissue microarray analysis was utilized to in-Understanding the cross talk between astroglia and neurite formavestigate the gene expression changes induced by EAE, and the subsetion is important for guiding the neurites to their targets, which has quent effects of MultiStem administration upon EAE-induced gene regenerative potentials for treatment of neurodegenerative diseases. expression changes. Animals treated with vehicle or 9 million cells This cross talk might occur through the integrin-associated protein were sacrificed and tissues harvested 3 days post-cell administration, CD47, which serves as a ligand for signal regulatory protein-α to assay immediate gene expression changes. The paradigm was re-(SIRPα). SIRPα takes part in synaptogenesis, and therefore the present peated at 28 days post-cell administration, to assess long-term gene study was focused on synaptophysin, a presynaptic protein, and its expression changes. Spinal cord, spleen, and blood microarray analypresence in relation to nerve fiber growth in organotypic tissue culses were performed using MouseRef-8 Illumina beadchips. Gene ontures from ventral mesencephalon (VM) of embryonic day (E) 14 and tology and pathway analyses outlined a number of significant gene E18 fetuses. In E14 cultures from CD47 knockout mouse, tyrosine expression changes induced by EAE that were reversed by MultiStem hydroxylase (TH)-positive nerve fiber growth was robust and indepenadministration. Within the spinal cord, significantly decreased expresdent of the presence of astrocytes, while in wild-type cultures nerve sion of genes related to neuronal projection organization and synapse fibers were restricted to the astrocytes. Most of the astrocytes were structure were seen in EAE animals and this was significantly reversed immunoreactive for synaptophysin in the CD47 knockout cultures but by MultiStem administration. Conversely, increased expression of a not in the wild-type cultures. The presence of synaptophysin was then large number of immune-related genes within the spinal cord was seen investigated in E14 and E18 cultures of rat VM. In E14 VM cultures, in EAE and this was significantly reduced by MultiStem admininerve fibers covered the most distally migrating astrocytes, indepenstration. Affected genes related to B-and T-cell-mediated immunity, dent of whether or not they were synaptophysin positive. In E18 antigen processing and presentation, and regulation of cytokine procultures, neurites grew to a definite border within the migrating astroduction. Blood and spleen microarray analyses showed similar imcytes, which reached much longer distances. Synaptophysin immunomune-related changes induced by EAE and modulated by MultiStem reactivity was only present in astrocytes associated with neurites. administration. The results of these studies suggest that treatment of Therefore, synaptophysin seems to play different roles during develop-MS patients with MultiStem may provide clinical benefit through mental stages and besides its presynaptic role, it appears to function modulation of the autoimmune dysfunction that is thought to contribas a permissive guiding molecule when associated with astrocytes. ute to the disease.
Thus, these data demonstrate the importance of the astrocytes as the main key player in guiding nerve fibers expressing synaptogenetic markers to modulate the neurite formation. Center, Durham, NC, USA of rat sympathetic neurons. We explored the neuroregenerative effects of BMP7 using rat primary cortical cultures. Cultures were continu-Many patients with temporal lobe epilepsy (TLE) display seizures ously exposed to BMP7 from DIV4 to DIV15 and exhibited a dosethat are resistant to antiepileptic drugs, and memory dysfunction. and time-dependent change in axonal and dendritic morphology based Hence, there is a need for novel therapies that both restrain spontaneon immunoreactivity to neurofilament (NF-H) and microtubule associous recurrent seizures (SRS) and improve memory function in TLE. ated protein 2 (MAP2), respectively. BMP7-treated cultures contained Neural cell grafting approach has the potential to serve as an alternalarge NF-H-immunoreactive fibers whereas untreated cultures showed tive therapy for TLE. γ-Aminobutyric acid (GABA)-producing cells a diffuse staining pattern of NF-H with small fibers. No changes were from the medial ganglionic eminence (MGE) appear ideal for grafting observed in glial fibrillary associated protein (GFAP) immunoreactivinto the hippocampus in TLE because the epileptic hippocampus exity, indicating that astrocyte morphology was unaffected by BMP7.
hibits an altered inhibitory function, and MGE cells have the ability These observed changes in neuronal morphology suggested alterations to produce hippocampal-specific GABAergic interneurons. Therefore, to extracellular matrix, so we next examined the effects of BMP7 on we examined the effects of grafting of freshly harvested MGE cells gelatinase and collagenase activity. Cultures were treated with BMP7 from the gestation day 14 rat brains into the hippocampi (3 grafts per on DIV4 until DIV11 when significant changes in NF-H immunostainside, 100,000 live cells/graft) of rats exhibiting TLE typified by SRS ing were observed. BMP7 caused a dose-dependent increase in gelatinand spatial memory dysfunction. The donor cells were labeled in vivo ase activity as early as DIV6. Collectively, our data show that BMP7 prior to harvesting via IP injections of 5′-bromodeoxyuridine into increases gelatinase activity and alters NF-H and MAP2 staining in pregnant rats at gestation days 10-14. Induction of TLE in host rats primary cultures. Our data suggest that the neuroregenerative effects was accomplished through graded IP kainic acid injections, which iniof BMP7 may involve gelatinase activation and alterations to extraceltially caused status epilepticus and later induced chronic epilepsy typilular matrix.
fied by SRS. A group of chronically epileptic animals exhibiting a similar frequency and intensity of behavioral SRS, and spatial memory dysfunction in a water maze test (WMT), was chosen for MGE cell grafting. The animals were implanted with epidural electrodes and continuous video-electroencephalographic (EEG) recordings were Graft-Induced Recovery in an Automated Habit Learning Task done for 2 weeks during the second month after grafting to measure the effects of grafting on both behavioral and EEG SRS. The animals A. Heuer, M. Lelos, A. E. Rosser, and S. B. Dunnett were next examined for spatial memory function in a WMT. The behavioral SRS were greatly reduced in epileptic rats receiving MGE Brain Repair Group, School of Bioscience, Cardiff University, precursor cell grafts. In comparison to their pregrafting scores, the Cardiff, UK reductions were 91% for the frequency of all SRS, 93% for the total percentage of time spent in SRS, and 100% for the frequency of stage Near complete unilateral dopaminergic depletion via infusion of 6-V seizures. Additional comparison with the epilepsy-only group rehydroxydopamine to the ascending dopaminergic bundle has been vealed that MGE precursor cell grafting greatly reduced both behavshown to lead to an impairment in contralateral space when animals ioral and EEG seizures. Analyses of spatial memory scores between had to perform on a lateralized choice reaction time task. In the present the pre-and postgrafting periods showed that MGE cell grafting eased experiment, naive rats were trained on an automated habit learning the memory dysfunction seen before grafting. Grafts demonstrated a task conducted in the rat nine-hole operant chamber. The animals had survival that was equivalent to ϳ30% of injected cells and a migration to perform a sustained nose-poke into the illuminated center hole of pattern that was somewhat restricted to the immediate surrounding rean array of nine holes with the two holes to the left or right of the gions of the graft core. Furthermore, grafted cells differentiated into center hole being available on alternating days, while the remaining large numbers of GABAergic neurons including the subclasses that holes were covered. After a variable delay a brief light flash in either are positive for neuropeptide Y, somatostatin, parvalbumin, and reelin.
the near or the far response hole from the center hole indicated the Thus, grafting of MGE precursor cells into the hippocampi of rats required response. All animals were trained on this task on each side exhibiting chronic TLE results in addition of substantial numbers of on alternating days before being matched into three groups. Whereas GABAergic neurons, reduction of both frequency and intensity of the untreated control group performed well on this task, animals that SRS, and an improved spatial memory function.
received unilateral lesions leading to near complete depletion of dopa-Supported by R01 NS 054780 and VA Merit Award to A.K.S. mine from one striatum displayed a bias towards the near hole when responses had to be made on the side contralateral to the lesion. Dopamine-rich dissociated cell suspension grafts were able to ameliorate some of the lesion-induced deficits on the operant task, including in-
Elevation of Cyclic AMP After Spinal Cord Injury by Electrical Stimulation of Hindbrain Raphe Nuclei: A Role for Serotonin
creasing the number of usable trials, a reduction in movement times, and a small increase in accuracy to far contralateral responses. These data confirm previous findings that this version of the lateralized I. Hentall, A. Vitores, and M. M. Carballosa-Gonzalez choice reaction time task is useful for assessing terminal dopamine depletion, which causes a response bias to near contralateral space, The Miami Project to Cure Paralysis, University of Miami Miller and extend the findings to the unilateral bundle lesion model. The School of Medicine, Miami, FL, USA bundle lesion causes a stable deficit that does not show signs of spontaneous recovery up to 50 days postlesion testing. Furthermore, the A common strategy to improve recovery after spinal cord injury task is sensitive enough to detect improvements by small dopamine-(SCI) is to support neuronal regeneration. Elevation of cyclic adenorich transplants and is therefore a valuable tool to assess cell replacesine monophosphate (cAMP) is one of the more promising of these ment and repair strategies. strategies. Many effects of cAMP are transcription dependent and promote the expression of regeneration-associated genes that could be Transplantation of Differentiated Human Embryonic Stem beneficial after SCI. Methods that have been used to increase the intra- Allen,* and A. E. Rosser † the contribution of serotonin release to this modulation of cAMP, we treated animals with pimozide, a potent antagonist of stimulatory Gprotein-coupled 5-HT7 receptors. Following a moderate T8 contusion, *Neuroscience, School of Biosciences, Cardiff University, rats were subjected to different treatments as follows: no ES, ES, Cardiff, UK pimozide (1.0 mg/kg) alone or in combination with ES. Control groups †Brain Repair Group, School of Biosciences, Cardiff University, received no injury. Intermittent stimulation was applied to the NRM Cardiff, UK for 2 h 3 days postinjury. The intracellular concentration of cAMP in cervical, thoracic, and lumbar sections was measured by enzyme-Therapies to replace the neuronal cell loss associated with neurolinked immunosorbent assay. The contusion injury reduced cAMP degenerative diseases to ameliorate the effects of diseases such as concentration in thoracic tissue proximal to the site of impact and also Huntington's disease (HD) are an attractive treatment paradigm. Our in cervical and lumbar tissue. Application of ES significantly increased group in recent years has tasked itself with understanding and driving intracellular cAMP in cervical and thoracic tissue of injured animals the neural differentiation of human embryonic stem cells (hESC) to when compared to the injured group that received no stimulation. Adneural progenitor cells suitable for HD cell replacement therapy. After ministration of pimozide led to a significant decrease in the levels of the progress made by ourselves and others in producing candidate dif-cAMP in all tissue in the injured nonstimulated groups compared to ferentiation culture protocols, we have more recently begun to examnoninjured groups. This decrease was not overcome by ES. These reine the challenges of downstream clinical applications such as further sults demonstrate that a few hours of ES in the NRM restores levels refining and converting our protocols to scale up while retaining cell of cAMP to near normal in spinal cord tissue near and remote to the phenotype and purity. Here we set out initial in vivo studies to detersite of injury. Thus, the proposed beneficial activity of the cAMP secmine efficacy and our ongoing strategy to further refine protocols, with ond messenger system on SCI is at least partially under serotonergic the goal of suitable clinical grade cultures. To generate cells suitable control.
for initial grafting experiments we built on previous neurosphere differentiation culture procedures, using two hESC lines (Hues9 and H9).
In vitro quality control measures of cultures routinely include flow cytometry and immunofluorescence microscopic analysis, and RT-qPCR panels of cell fate markers [such as pluoripotent markers (OCT4, NANOG), neural progenitor markers (PAX6, SOX1), and rostrocaudal neural identity (FOXG1, DBX1, EN2, and HOXB4)]. Cell 564 ABSTRACTS culture scale-up experiments were undertaken using a Novapod (Med-No treatment currently exists to restore lost neurological function after stroke or spinal cord injury. The transplantation of stem cells or Cell) bioreactor, which produced a greater yield of more homogeneous neurospheres, compared to static dish cultures. During these initial progenitors may support neural repair. In this study, we used humaninduced pluripotent stem cell (IMR90)-derived neural precursors (iPS-scale-up studies morphological and gene expression analysis showed progression of neural progenitor differentiation, suggesting they are NPs) for transplantation in a rat middle cerebral artery occlusion (MCAO) model of stroke or a balloon-induced spinal cord compres-suitable for ongoing graft studies. Our protocol development strategy examined the effects of dose regimes of exogenous factors and animal sion lesion (SCI). Neural precursors were derived from iPS through the microaggregates stage using 300 ng/ml noggin and 20 µM SB. product replacement substitutes upon phenotypic fate, and included the testing of Good Manufacturing Practice (GMP)-compatible media Prior to in vivo experiments, in vitro analysis of iPS-NPs was performed. Subsequently, the percentage of cells expressing markers of and supplements, together with the substitution of growth factors with small molecules. Derived cells were grafted into a unilateral quinolinic neural precursors, including oct3/4, sox2, SSEA-4, SSEA-1, TRA-1-60, CD24, CD133, CD56, βIII-tubulin, NF70, nestin, CD271, and acid rat HD model and assessed for graft survival (HuNu), proliferation (Ki67), morphology, and differentiation (NeuN, FoxP1, DARPP32) CD29, was assessed by fluorescence activated cell sorting (FACS) in undifferentiated and predifferentiated [fibroblast growth factor (FGF) using immunohistological investigation. We examined graft survival and morphology at 12 weeks postgraft, and further validated a desensi-and epidermal growth factor (EGF) omitted from the culture medium (CM) for 7 days] NPs. Female Sprague-Dawley rats were subjected to tization protocol that will facilitate long-term graft studies in the rat model. Throughout these studies graft cell morphology and gene ex-focal cerebral ischemia by reversible right MCAO for 90 min, while male Wistar rats were used for SCI. A suspension of iPS-NPs (300,000 pression analysis showed progression of neural progenitor differentiation. While there is considerable way to go in refining the "neural cell cells in 3 µl of CM) was transplanted into the lesions 7 days after MCAO or SCI (n = 14, n = 12); the control groups (n = 8) were in-replacement strategy" for transplantation in neurodegenerative diseases, these data demonstrate our continuing systematic approach to jected with saline. Metabolic profiles in the striatal tissue of both hemispheres were assessed by magnetic resonance spectroscopy protocol development. In doing so, establishing standard procedures and quality assessments that are increasingly compatible with the (MRS) in the MCAO model. Four months after MCAO, MRS revealed that the concentrations of brain metabolites (glutamate, glutamine, N-needs of future clinical grade production of cells suitable for transplantation in HD and other neurodegenerative diseases.
acetyl-aspartate, creatine, taurine, choline, and inositol) in grafted animals returned nearly to the values found in unlesioned animals. Func-This work is supported by a grant from the MRC. protective agent that ameliorates neuronal cell death. However, the molecular mechanism by which CsA interacts with mitochondrial K. S. Jones and B. Connor membrane-associated proteins, which regulate mitochondrial membrane potential (∆ψ m ), and with neurotrophic factors remains an Department of Pharmacology and Clinical Pharmacology, enigma. We examined CsA in an hypoxic-ischemia in vitro model in Centre for Brain Research, Faculty of Medical and Health Sciences, which we exposed primary rat neural cells to oxygen glucose depriva-University of Auckland, Auckland, New Zealand tion (OGD), and found that pretreatment of primary rat neural cells with CsA increases neuroprotective effects, which increase cell viability and decrease oxidative stress during OGD periods, in comparison Compensatory replacement of neurons by endogenous subventricuwith the administration of CsA after ischemic insults. CsA prevented lar zone (SVZ)-derived neural precursor cells (NPCs) has been demon-1) depolarization of the mitochondrial membrane from OGD via strated in the adult brain following striatal cell loss. Such cell replaceblocking the formation of the mitochondrial permeability transition ment is associated with increased SVZ cell proliferation and neuroblast pore complex, 2) release of cytochrome c, which turns on the caspasesexpansion in the rostral migratory stream (RMS), as well as directed induced apoptotic signal pathway, and 3) induction of the mtDNA fragmigration of NPCs extending from the SVZ to the areas of striatal mentation. This efficacy occurred in a dose-dependent manner and damage. However, the number of new neurons that migrate into the over a longitudinal time scale. Interestingly, CsA does not signifilesioned striatum and survive is low. SVZ-derived NPCs coexpress cantly influence mitochondrial reductase activity, suggesting that CsA multiple transcription factors involved in lineage restriction and cell would not be neurotoxic but instead an alternative neuroprotective sigfate determination. We propose that compensatory neurogenesis in renal transduction. CsA selectively binds calcineurin, a Ca 2+ -calmodulinsponse to striatal cell loss will alter the temporal expression of trandependent phosphatase that is highly enriched in the brain, and signifiscription factors in discrete populations of SVZ-derived NPCs. We cantly inhibits its activity, which regulates plasma membrane depolartherefore examined the expression of mammalian achate schute homoization by dephosphorylation of Na + /K + -ATPase. We found that CsA log 1 (Mash1), homeobox protein distal-less (Dlx2), paired box gene would cross talk with dopamine cAMP-regulated phosphoprotein-32 6 (aniridia, keratitis) (Pax6), and oligodendrocyte transcription factor to maintain neuronal cell homeostasis and that, furthermore, CsA en-2 (Olig2) in SVZ-derived NPC populations across a range of times hanced DJ-1, a Parkinson disease-associated protein, translocation in following quinolinic acid (QA)-induced striatal cell death. We identithe mitochondria and secretion of DJ-1 into neighboring neuronal cells fied a heterogeneous population of SVZ-derived NPCs that respond with reduced oxidative stress after OGD. This pilot study further supindependently to striatal cell loss. In both the anterior SVZ (aSVZ) ports the notion that CsA is intimately associated with early phases of and RMS we observed an increase in a subpopulation of Dlx2 + transit disease progression in stroke. amplifying precursor (TAP) cells and neuroblasts following QA lesioning when compared to controls. Subsequently, the number of Pax6 + TAPs and neuroblasts in the QA-lesioned aSVZ and RMS was also increased. This suggests that Dlx2 and Pax6 may play an impor-
Transplantation of Human Amniotic Mesenchymal Stromal tant role in directing NPC proliferation and neuroblast generation fol-Cells Via the Jugular Vein at Subacute Period of Neonatal lowing striatal cell loss. Selective alteration of these factors in the SVZ
Hypoxic-Ischemic Injury in Rats Promotes Long-Term in response to cell loss may predetermine the subsequent generation
Behavioral Improvement of specific neuronal subclasses for endogenous replacement. Retroviral green fluorescent protein (RV-GFP) tracing studies showed that ). Here, we tested whether IV hAMSC also renders therapeutic effects in a fying the temporal dynamics of specific transcription factors within the SVZ-RMS pathway in response to brain cell loss will expand our neonatal rat model of cerebral palsy (CP). CP in the neonate occurs in about 10 of 1,000 full-term infants in the US. The current state of the knowledge regarding the process of adult neurogenesis and may indi-566 ABSTRACTS art for treating CP is hypothermia, but only neonates with moderate preliminary studies from our laboratory revealed that primate kinesin heavy chain levels are reduced by 1-methyl-4-phenyl-1,2,3,6-tetrahy-encephalopathy appear to exhibit the most favorable neurodevelopmental outcome. Hence, there is a clinical need to repair the already dropyridine (MPTP; 807.49 ± 108.7; p < 0.01) and are not restored to control levels (1382.54 ± 129.56) despite intense dopaminergic marker damaged regions requiring a cellular replacement approach that may be applicable for neonates with moderate to severe CP. CP and adult expression by residual nigral neurons. Recently published work from our laboratory further demonstrated that lysosomal and proteasomal stroke share similar pathophysiological manifestations. Cell therapy has been explored in the clinic as an experimental treatment for stroke markers are significantly decreased in neurons displaying α-syn-ir inclusions in a mutant human α-syn nigral overexpression rodent model over the last decade and was recently initiated for CP patients. Whether functional recovery in transplanted CP is directly influenced of PD (Chu et al., 2009). Our central hypothesis is that systemically administered LPS will cause changes in protein aggregation, protein by the dose of the transplanted cells remains to be fully determined. An ample supply of stem cells can be harvested from the amnion that clearance pathways, and axonal transport mechanisms that mimic those alterations seen in PD patients. It is our long-term goal to clarify should allow autologous transplantation in CP. We used the established Vannucci rodent model of CP, involving the ligation of a unilat-the sequential underlying neuronal pathology leading to SNpc DA cell death in PD. The achievement of this goal might establish preclinical eral carotid artery in a postnatal day 7 rat followed by exposure to systemic hypoxia (8% oxygen) for 2.5 h. The model produces injury disease biomarkers leading to more effective pharmacotherapies and potential neuropreventative strategies. to the cerebral cortex, subcortical and periventricular white matter, striatum, and hippocampus on the side of the ligation, as well as behavioral deficits similar to that seen in human neonates with CP. Sprague-Dawley rats received a unilateral SN injection of adeno-asso-Rush University Medical Center, Chicago, IL, USA ciated virus (AAV)-wtSNCA, AAV-S129A SNCA, or AAV-S129D SNCA either with or without a portion of the 3′UTR that included the micro-RNA-7 binding site. DA neurons in SN that maintained projec-Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder and is clinically characterized by a battery of debilitat-tions to ST at the end of treatment were labeled using retrograde transport of fluorogold (FG). Rats received bilateral ST FG injections 5 ing and painful motor and nonmotor symptoms. Pathologically, motor symptoms manifest when striatal dopamine (DA) levels are decreased days before perfusion at 5, 7, or 9 weeks postinjection, and FG-positive neurons in both SN were counted. At 5 weeks postinjection, rats ϳ80%, which correspond to ϳ60% loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Currently, the only avail-injected with SNCA forms that did not contain the 3′UTR had reduced FG-positive neuron numbers in injected SN compared to uninjected able treatments for PD patients temporarily suppress some symptoms but fail to slow the degenerative process. While the postmortem par-SN (wtSNCA, p < 0.05; S129A or S129D SNCA, p < 0.01). In contrast, FG-positive neuron numbers were not significantly different be-kinsonian profile is well characterized, etiopathogenic events early in the disease process are poorly understood. Effectively modeling the tween injected and uninjected SN when the 3′UTR was included for all SNCA forms. These data suggest that inclusion of the 3′UTR pro-pathogenic process leading to SNpc cell death in PD may be important for developing neuroprotective strategies. A recent series of studies tects against the hSNCA-induced loss of ST-projecting DA neurons in the SN in vivo. When the percent of FG-positive cells (injected/unin-using systemically injected lipopolysaccharide (LPS) have shown delayed and progressive decreases in SNpc DA neurons in mice (Qin et jected SN) was examined, S129A SNCA (without the 3′UTR) resulted in the lowest percent of FG-positive neurons, but this was only statisti-al., 2007; Liu et al., 2008). In this model, 2-month-old male C57BL/ 6J mice receiving 5 mg/kg IP LPS display a significant (23%) loss of cally significant (p < 0.05) when compared to S129D SNCA (without the 3′UTR). These data suggest that phosphorylated and unphospho-tyrosine hydroxylase (TH) nigral neurons at 7 months that progresses to 47% loss over 10 months. Additionally, chronic neuroinflammation rylatable hSNCA mimics both have a toxic effect on nigrostriatalprojecting DA neurons at 5 weeks, although S129D SNCA is less toxic and increased α-synuclein (α-syn), the primary protein abnormally aggregated in pathogenic Lewy bodies, are observed. Using this model, than S129A SNCA. Analysis of effects on ST-projecting DA neurons at 7 and 9 weeks are currently in progress, but preliminary data sug-initial studies from our laboratory revealed that striatal anterograde transport protein kinesin heavy chain levels are significantly decreased gest that wtSNCA and S129D SNCA-treated rats exhibit some recovery by 9 weeks compared to S129A SNCA-injected rats and that inclu-(20.81 ± 0.91; p < 0.05) from saline-treated controls (25.55 ± 1.96) at 4 months, whereas no differences were observed at 3 months (15.19 ± sion of the 3′UTR still protects against S129A SNCA-induced degeneration. These data support the hypothesis that micro-RNA dys-1.23 and 15.36 ± 1.34 for LPS and saline, respectively). Additional regulation is involved in PD pathogenesis and suggest that delivery of agents (7 males, median age 58.5 years; median disease duration 1.5 years) underwent unprepped flexible sigmoidoscopy with biopsy of micro-RNA-7 could be developed as a novel therapy for PD.
Supported by grants from the Department of Defense NO06079001, the distal sigmoid colon. Immunohistochemistry studies for αSYN and 3-NT were performed on biopsy specimens and control specimens NIH NS054989, and T32 NS041234 and the Chicago Biomedical Consortium.
from a tissue repository [23 healthy subjects and 23 subjects with inflammatory bowel disease (IBD)]. Nine out of the 10 PD samples were adequate for study. All showed staining for αSYN in a pattern suggesting nerve fibers in colonic submucosa. A similar pattern was Skilled Reaching Behavior in a Rat Model of Huntington's seen in one additional subject whose biopsy was taken 5 years prior Disease and the Effects of Neurorestorative Therapy to the diagnosis of PD. No control sample showed this pattern. A few showed light αSYN staining in round cells. 3-NT staining was seen A. Klein,* E. L. Lane, † and S. B. Dunnett* in 87% of PD cases, but was not specific for PD. This study suggests a pattern of αSYN staining in PD that was distinct from healthy and *Brain Repair Group, School of Biosciences, Cardiff University, IBD subjects. Absence of this pattern in IBD subjects suggests that it Cardiff, UK is not a sequelae of inflammation or oxidative stress because 3-NT immunostaining was common in all groups studied. These data suggest †Welsh School of Pharmacy, Cardiff University, Cardiff, UK that αSYN expression for biopsies derived from unprepped flexible sigmoidoscopy of the distal sigmoid colon may be an easy, inexpen-Skilled limb movements are severely impaired during the course sive biomarker for the occurrence of PD. of Huntington's disease (HD). Thus far, little attention has been paid to the qualitative and detailed analysis of reaching-for-food movements (i.e., skilled limb movements) in the context of the quinolinic Plasticity in the Phrenic Motor System Following High Cervical acid (QA) lesion rat model and brain repair. In the present study we Spinal Cord Injury in Adult Rats investigated rodent reaching behavior including a neurorestorative approach using fetal whole ganglionic eminence (wGE)-derived grafts. M. A. Lane,* K. Z. Lee,* D. F. Ryczek,* D. D. Fuller, † Twenty-one Lister-Hooded rats were unilaterally infused with QA into and P. J. Reier* the dorsolateral striatum contralateral to their preferred paw. Eleven rats served as nonoperated controls. Six weeks after the lesion, 11 rats received 2 µl of an E15 wGE cell suspension into their ipsilateral *Department of Neuroscience, University of Florida, striatum (1 wGE/2 µl). Ten rats were sham transplanted. Before and Gainesville, FL, USA after the lesion and following transplantation, the rats' motor behavior †Department of Physical Therapy, University of Florida, was analyzed in the single pellet reaching test using a movement ele-Gainesville, FL, USA ment score and the side-stepping/paw-placing paradigm. One week prior to perfusion the rats received a FluoroGold injection into the Cervical spinal cord injury can compromise phrenic motor pathglobus pallidus. The rats were transcardially perfused 19 weeks postways, impairing diaphragm function and breathing, and such injuries transplantation. The qualitative analysis of reaching behavior revealed in people often necessitate assisted ventilation. However, experimental that striatal grafts had a strong beneficial effect on the rats' perforstudies have revealed plasticity within the phrenic motor system that mance in the single pellet reaching test. Interestingly, individual movecan mediate functional recovery. Immediately following a lateral C2 ment elements responded differently to the grafts. Particularly distal hemisection (C2Hx) the ipsilateral diaphragm is paralyzed, but spontarotatory limb movements were most impaired, but also well restored; neous recovery has been reported within weeks. While a number of however, most movement elements returned to control levels after studies have begun examining anatomical changes within the ipsilatgrafting, indicating a near complete restoration of reaching patterns. eral phrenic motor system, less attention has been given to contralat-Reaching success of grafted rats nearly doubled compared to shameral pathways. The present work examines anatomical and functional transplanted rats, but still did not achieve performance equal to the changes in the ipsi-and contralateral phrenic pathways postinjury. control rats. Our results indicate that wGE grafts are an effective Adult female rats received a lateral hemisection of the C2 spinal cord. method to restore (at least partially) individual skilled limb movements Plethysmography was used to assess ventilation pre-and postinjury. in the QA-lesioned rat and support the continuing development of cell Measurements were made under baseline (breathing normoxic, normotransplantation as a potential future therapy for HD. capnic air) and hypercapnic (7% CO 2 ) conditions. All animals were then left to recover for 1-12 weeks postinjury. At the end of the study, a subset of animals was terminally anesthetized to assess diaphragm activity. Bilateral diaphragm electromyography (EMG) recordings was much less than that seen contralaterally. Transneuronal tracing of Chicago IL, USA the contralateral phrenic motor system revealed labeling in a subset of interneurons rostral to the injury. Alterations in the contralateral phrenic motor system may represent adaptive plasticity associated with The diagnosis of Parkinson's disease (PD) rests on motor signs of advanced central dopamine deficiency. There is an urgent need for compensatory activity in this circuit. Work is under way to determine how activity in each phrenic pathway may contribute to postinjury disease biomarkers. Clinicopathological evidence suggests that αsynuclein (αSYN) aggregation, the pathological signature of PD, can breathing. Collectively, these results reveal changes in the phrenic motor system contralateral to C2Hx that likely reflect compensatory plas-be detected in gastrointestinal tract neurons in PD. We studied whether we could demonstrate αSYN pathology in specimens from unprepped ticity and underscore its importance in maintenance of breathing postinjury. Studies aimed at enhancing phrenic recovery ipsilateral to flexible sigmoidoscopy of the distal sigmoid colon in early PD subjects. We also looked for 3-nitrotyrosine (3-NT), a marker of oxidative C2Hx and optimizing restorative plasticity need to consider how such treatments also may affect compensatory plasticity. stress. Ten subjects with early PD not treated with dopaminergic 568 ABSTRACTS
Nutritional Supplementation if NT-020 in Aged Rats Promotes hESC Differentiation to Midbrain Dopaminergic Neurons Is Enhanced in Lines With Amplified 17q21.31 Wnt an Environment Permissive for Stem Cell Genesis
Signaling to large chromosomal abnormalities including trisomies of chromosomes 12, 17, and/or X as well as more subtle genetic abnormalities. Five karyo-Neural stem cells have the ability to self-renew and replenish damtypically normal hESC lines (BG01, 02, 03, ES02, 04) and one karyotypaged neurons; these cells can be used in cell replacement therapy for ically abnormal trisomy 17 hESC line (BG01V2) were characterized for neurodegenerative diseases. It has been clearly established that the sysmorphology, proliferation, cell survival, growth factor dependence, abiltemic environment of an aged animal has significant impact on stem/ ity to differentiate into dopamine cell precursors, and copy number variaprogenitor cell function in many parts of the body. This has been demtion (CNV). All hESC lines displayed similar cell survival rates, normal onstrated with the technique of heterochronic parabiosis where the cirmorphology, and well-defined colony boundaries. BG01V2 and BG03, culations of a young and aged rat are combined together. Under these however, showed enhanced rates of proliferation. After withdrawal of circumstances, it has been observed that aged progenitor cells in the fibroblast growth factor-2 (FGF-2), BG01V2 and BG03 lost pluripotency liver, muscle, and many other tissues when exposed to the circulation rapidly, displaying enhanced differentiation. DA neuronal differentiation of a young rat increased proliferation and regeneration index. Previous was assessed using the protocol described by Yan et al. (Stem Cells, studies have shown that use of dietary supplements with distinct anti-2005). This method involves culture in the presence of FGF-2 and FGFinflammatory properties can restore deficits in adult neurogenesis. One 8 to yield neuroepithelial (NE) cells after 16 days, isolation and culture such natural product formulation, termed NT-020, shows particular in the presence of FGF8 and sonic hedgehog (SHH) to yield mesencepromise and our studies have shown effects of this supplement to inphalic DA (mDA) progenitor cells, and production of mature DA neurons crease neurogenesis in vivo. We hypothesize that NT-020 modulates by 45 days. BG01V2 and BG03 exhibited superior neuroectodermal systemic factors to enhance stem/progenitor cell genesis in the young specification, with more nestin-positive cells and fewer Oct3/4-positive host and decrease proliferation and regeneration in the aged host by cells at the NE stage. BG01V2 and BG03 also displayed more rapid DA using this parabiotic technique. To examine this, we used serum samdifferentiation than the other lines, as evidenced by the presence of DA ples collected from young (n = 8), aged (n = 8), and aged-treated (n = progenitor cells that expressed Lmx1A + , Otx2 + , and Msx1 + as well as DA 7) male Fischer 344 rats. Aged rats were treated for 4 weeks with 135 neurons that expressed tyrosine hydroxylase (TH) and Tuj1 at the NE mg/kg/day of NT-020 incorporated into the diet while young and aged cell stage. The enhanced mDA differentiation of BG01V2, which had an control rats were given control NIH31 diet. Adult rat hippocampal extra copy of chromosome 17, suggested that enhanced differentiation of neural stem cells were grown in neural basal media for 24 h, and then BG03 might also be linked to extra chromosome 17 genetic material. We exchanged for fresh media with either 10% FBS or serum for 2 addithus assessed CNVs on chromosome 17 using Affymetrix 6.0 arrays. A tional days. Proliferation of neural stem cells was assessed via bromogenomic duplication located between 41.3 and 42.5 Mb at 17q21.31 was deoxyuridine (BrdU) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylteidentified in BG03. This CNV encompasses the WNT3-WNT9 cluster trazolium bromide (MTT) assays. Serum samples from aged control of genes implicated in pluripotency, proliferation/survival, and differentirats on BrdU assay significantly decreased proliferation in comparison ation. Additional copies of WNT3 and WNT9B in both BGO1V2 and to aged rats treated with NT-020 (Y: 43.4 ± 7.4, A: 8.40 ± 1.6, A-NT: BGO3 were confirmed by qRT-PCR. In addition, expression of both 30.1 ± 5.0; ANOVA: F = 11.6, p < 0.05). Using the MTT assay, serum WNT3 and WNT9B mRNAs was increased during mDA differentiation samples from aged control rats again significantly decreased in comin BG01V2 and BG03 cells. Using Western blotting, canonical WNT3 parison to aged rats treated with NT-020 (Y: 0.61 ± 0.1, A: 0.39 ± 0.1, and noncanonical WNT9B signaling inhibitors (Dkk-1 and SP600125, A-NT: 0.87 ± 0.1; ANOVA: F = 8.92, p < 0.0001). In conclusion, our respectively), and a ChIP assay, we found that WNT9B promotes neudata suggest that NT-020 supplementation promotes neural stem/proroectodermal fate through inhibiting hESC self-renewal. WNT3 stimugenitor cell proliferation by modulating systemic factors in the aged lates both NE proliferation and mDA differentiation. Thus, amplification rat brain as this may be a potential therapeutic target for combating of the 17q21.31 WNT3-WNT9B cluster enhances mDA differentiation age-related diseases. Future studies will address whether NT-020 acts in hESC. Elucidating the roles that WNT signaling plays during mDA on the brain's main immune cells, the microglia, or that circulating differentiation can help optimize strategies for inducing mDA differentiaproinflammatory cytokines and/or chemokines mediate its effects, and tion of hESC. identify signaling molecules that may be present in serum that effect
Research supported by the IRP of NIDA, NIH, DHHS. stem/progenitor cell function. Parkinson's disease is characterized by the loss of dopaminergic NES cells and, secondly, to determine the viability and integration potential of the cells after grafting into the striatum of immunosup-neurons in the substantia nigra. Unfortunately, current treatment strategies are only palliative, and long-term consequences of ablative sur-pressed mice at different time points postlesion. To this end, three groups of mice were given quinolinic acid lesions of the neostriatum gery and deep brain stimulation are as yet unknown. Pulsed electromagnetic fields (PEMF), used to facilitate bone repair and reduce pain and were grafted either 6 months postlesion (long term), 2 months postlesion (midterm), or 10 days postlesion (short term). As the exper-and swelling from soft-tissue injuries, have recently been configured to affect calmodulin (CaM)-dependent signaling, which will modulate iment is currently ongoing, grafts will be harvested at two time points, 6 and 12 weeks, posttransplant and tissue will be evaluated by immu-biochemical cascades involving nitric oxide and cyclic nucleotides that lead to tissue regeneration and angiogenesis. Importantly, these mole-nohistochemical analyses for a number of neuronal and glial markers, including HuNu, nestin, Tuj1, GFAP, Gad67, GalC, and Ki67. Given cules are also mediators of neuronal survival and differentiation. In this study, we tested the effects of PEMF signals on neuronal survival that transplant time postlesion has been shown previously to affect axonal growth and functional efficacy of dopaminergic cell trans-and plasticity in cell culture. The murine MN9D dopaminergic cell line was a gift from Alfred Heller (University of Chicago). Cells were plants, it is expected that greater survival and integration of these GABAergic cells will be evident in cells transplanted 10 days postle-plated at 100,000 cells/35-mm dish in Dulbecco's modified Eagle's medium (DMEM) in the presence or absence of 10% fetal calf serum sion, relative to those transplanted 6 months postlesion. Furthermore, it is anticipated that the in vivo differentiation profile of the PKd NES and 1 mM dibutyryl cyclic adenosine monophosphate (Bt 2 cAMP). At 1 day, cultures were divided into groups and treated with a nonthermal cells may yield information regarding the proliferation potential and the time course of GABAergic and glial cell differentiation and inte-radiofrequency PEMF signal (27.12 MHz carrier frequency, 0.05 Gauss, 4 ms burst width, 2 Hz), for either 2 × 30 min/day or 15 min/ gration. These data are important for expanding knowledge of both iPS-derived cell lines for cell replacement therapies and optimizing h for 3 days. Control cultures were exposed to the same conditions without PEMF signals. After treatment, cells were fixed and photo-parameters for transplantation of cells into the brain. graphed for image analysis. Neurite length, total cells, and number of cells with processes were quantified in four consecutive fields under phase optics at 100× magnification. Data were analyzed and tested for
The Effects of Hematopoietic Growth Factors on Clearance statistically significant differences between treatment groups with the of Amyloid-Beta Deposition and Improvement of Cognitive Student's t-test. Values of p ≤ 0.05 were considered significant. Re-Function in APP/PS1 Transgenic Mice moval of serum increased neurite length compared to cells maintained in 10% serum. Thirty-minute exposure to PEMF 2×/day for three days B. Li,* X. Liu,* and L.-R. Zhao* † increased differentiated cells by 47% (p = 0.02) and increased neurite length by 43% (p = 0.03). No differences were found in total cell num-*Department of Neurology, Louisiana State University Health bers. In 10% serum, PEMF treatments of 15 min/h for 3 days resulted Sciences Center, Shreveport, LA, USA in a 25% increase in neurite length (p = 0.04). Results suggest that †Department of Cellular Biology and Anatomy, Louisiana State PEMF signals configured to modulate CaM-dependent signaling increase neurite outgrowth under conditions that both facilitate and in-University Health Sciences Center, Shreveport, LA, USA hibit differentiation using two different treatment regimens. Effects of PEMF signals were also compared with those of cAMP, a known in-Alzheimer's disease (AD) represents the most frequent cause of ducer of neurite outgrowth. Addition of 1 mM Bt 2 cAMP significantly dementia and the sixth leading cause of death in the US. Currently, increased neurite length by 41% (p = 0.001); however, PEMF treatthere is no approved treatment with a proven disease-modifying effect ment in the presence of cAMP did not further increase neurite length, for AD. Therefore, developing therapeutic strategies for AD is a critisuggesting that this was achieved through a common mechanism that cal need. Substantial evidence shows that abnormal accumulation of reached its maximum effect with 1 mM cAMP. While neuritogenesis amyloid-beta (Aβ) in the brain is a direct cause of neurodegeneration occurs during brain development, it may also represent the plasticity and cognitive decline in AD. In our early study, we have demonstrated required to form and maintain synaptic connections throughout life.
that the combination of two hematopoeitic growth factors, stem cell The authors would like to thank Jonathan Rasouli, Parviz Lalezari, factor (SCF) and granulocyte-colony stimulating factor (G-CSF) (SCF and Berish Strauch for all their help and support. Supported in part + G-CSF), decreases Aβ deposition and improves cognitive perforby NIH grant R21 NS052576 and Ivivi Health Sciences.
mance in a mouse model of AD (APP/PS1 transgenic mice). The purpose of this study is to determine long-term therapeutic effects of SCF and G-CSF alone, or in combination in APP/PS1 mice. SCF, G-CSF, SCF + G-CSF, or equal volume of saline were subcutanousely admin-
Transplantation of IPS-Derived NES Cells in CD1 Mice:
istered for 12 days. Aβ deposits in the brain were determined with live live APP/PS1 mice showed a significant reduction in Aβ deposition in the cortex 7 days after the initial treatment. At this point, the num-Brain Repair Group, School of Biosciences, Cardiff University, ber of bone marrow-derived microglia and the colocalization of bone Cardiff, UK marrrow-derived macroglial cells and Aβ deposits in the cortex and hippocampus were significantly increased in SCF + G-CSF-treated Given the ethical and logistical issues surrounding the use of fetalmice. In addition, both escape latency and swimming distance in the and embryonic-derived cells in cell replacement therapies for neuromice treated with SCF + G-CSF were significantly shorter than those degenerative disorders, the advent of induced pluripotent (iPS)-derived in the groups of saline, SCF, or G-CSF alone at 3 and 7 months after neural cells may offer a safe and viable alternative. At present, howtreatment. Furthermore, SCF + G-CSF-treated APP/PS1 mice disever, little data exist regarding the ability of iPS-derived neuroepitheplayed a significant reduction in the levels of Aβ 1-40 and Aβ 1-42 lial (NES) cells to survive and differentiate in vivo. Furthermore, there in brain tissue compared to saline controls, SCF, or G-CSF alone 8 exists experimental evidence demonstrating that the age of the transmonths after treatment. These data suggest that SCF in combination plant recipient influences the profile and function of the grafted cells.
with G-CSF has synergistic and long-lasting effects in removal of Aβ In the clinical setting, Huntington's disease (HD) patients would typideposits and improvement of cognitive function. This study provides cally be considered suitable for cell replacement therapy several years new insights into the contribution of hematopoietic growth factors in after the onset of neurodegeneration. Despite this, grafts are typically the treatment of AD. assessed for survival and function in young rodent models of HD This study was supported by The Franks' Foundation and Louisishortly after lesion. Thus, the aim of the current experiment was, ana Gene Therapy Research Consortium. firstly, to assess the time course of in vivo differentiation of "PKd" 570 ABSTRACTS
Precise MeCP2 Phosphorylation Affect Adult Neurogenesis
hand, the ubiquitously distributed matrix metalloproteinases with collagenase activity in living tissues including the brain may be possible culprits to degrade gelatin in vivo. To conclude, the use of biomateri-H. Li, K. F. C. Chau, and Q. Chang als for stem cell encapsulation and improvement of cell survival is on the rise. By providing molecular information on the composition and Waisman Center, University of Wisconsin-Madison, Madison, WI, USA degradation of scaffold materials, CEST MRI could become a valuable tool for studying dynamic changes in scaffolds in vivo and allow fur-Methyl CpG binding protein 2 (MeCP2) plays a central role in ther optimization of implantation strategies aimed at improved stem DNA methylation-dependent epigenetic regulation of the development cell therapy. and function of the nervous system. Recent studies suggest that MeCP2 may regulate neuronal differentiation and maturation through Use of BLI Reporter Genes for Stem Cell Imaging: micro-RNAs. Our lab is interested in understanding the in vivo func-Comparison of Red-Shifted Firefly Luciferase Ppy RE9 tion of neuronal activity-induced MeCP2 phosphorylation. During the and Conventional fLuc2 process of analyzing several lines of Mecp2 phosphomutant mice, we found that independent phosphorylation events on the MeCP2 protein Y. Liang,* † P. Walczak,* † and J. W. M. Bulte* † had opposing effects of the proliferation and differentiation of adult synaptic excitation in the dentate gyrus contribute to the development 33:689-702, 2002) and it may promote activity-dependent axon growth (Ben-Ari, TINS 24:353-360, 2001). One week after denerva-of spontaneous recurrent seizures in temporal lobe epilepsy (TLE). Adults with mesial temporal lobe epilepsy (MTLE), a common form tion by sciatic nerve section, embryonic day 14-15 cells were injected into the tibial nerve of adult Fischer rats. The transplanted cells were of partial epilepsy, often have severe, drug-resistant focal seizures in limbic brain regions, including the hippocampus, amygdale, and ento-then stimulated at high frequency (20 Hz), low frequency (1 Hz), or not at all for 1 h. Groups controlling for stimulation frequency, pattern, rhinal cortex, with concomitant cognitive impairments. The diseasemodifying effects of γ-aminobutyric acid (GABA)-ergic progenitor and pulse number were included. Assessments were made 10 weeks later. Acute electrical stimulation of transplanted cells for 1 h at 1 Hz: transplants were investigated in mice with MTLE. Adult male mice were treated systemically with the cholinergic agonist pilocarpine to 1) increased the number of myelinated axons in the tibial nerve compared to no stimulation; 2) improved muscle reinnervation because induce status epilepticus (SE) and subsequent development of spontaneous, recurrent seizures (SRS) over the course of several weeks. After higher proportions of muscle fibers had large areas. All groups that received stimulation for 1 h had more functional muscles and motor the development of SRS, embryonic day 13.5 GABAergic progenitors were harvested from the medial ganglionic eminence (MGE) of fetal units. These data suggest that acute electrical stimulation of embryonic neurons in nerve enhances axon regeneration, muscle reinnervation, mice expressing enhanced green fluorescent protein (EGFP) in all tissues. Alternatively, some grafts consisted of MGE progenitors that and function, resulting in reduced denervation-induce muscle atrophy. Funded by NS-39098, State of Florida Appropriation 546, and The were nucleofected with red fluorescent protein (RFP). High levels of RFP expression in axons and dendrites of the transplanted cells al-Miami Project to Cure Paralysis. lowed us to visualize at the single cell level how they formed connections within host brain neural circuits. Between 100,000 and 200,000
Incorporating Regenerative Medicine Techniques cells were stereotaxically transplanted bilaterally in either the hilus of is an Outpatient Orthopedic Setting the dentate gyrus or the lateral entorhinal cortex. Spontaneous seizures were then monitored using continuous video-electroencephalographic D. Lox recordings (v-EEG) for periods of up to 100 days. A gradual suppression of SRS over the course of the recording period was observed in Florida Spine Center, Clearwater, FL, USA the group of mice receiving hilar MGE grafts. There was a statistically significant reduction in the mean number of seizures in the MGE In today's healthcare environment, we are met with rapid changes. transplant group compared with media-injected controls. The effects
Managing acute and chronic painful conditions often employs a variwere observed by 6 weeks posttransplantation and lasted up through ety of treatment options; however, the natural degenerative cascade 100 days of continuous v-EEG monitoring. To determine whether the continues. Embracing regenerative therapies to treat degeneration is size of the grafts could account for their ability to suppress SRS, we discussed, with a look at how platelet-rich plasma (PRP), stem cells, reconstructed the transplants and measured graft volumes. Despite the nutraceuticals, and telomerase activators may impact our lives. fact that the cells showed robust survival and extensive connections with the host brains, there was not a strong correlation between overall Regulation of Neural Differentiation by Ryk-Mediated graft size and degree of seizure suppression. The molecular properties Wnt Signaling of the cells were also examined and we determined that over 80% of the cells were GABAergic interneurons and a majority of these expressed the neuropeptide somatostatin. Although the percentage of W. Lu, S. Choi, J. Lyu, J. Zhong, and H. Kim GABAergic interneurons was comparable in the dentate and entorhinal grafts, only the mice with dentate gyrus transplants showed marked To determine the role of endogenous NPCs, experi-ronal lineages will contribute not only to 1) understanding of the development, evolution, organization, and function of CNS circuitry, ments in which host NPC proliferation and neurogenesis was inhibited using cytosine-β-D-arabinofuranoside (Ara-C) have been conducted. but also to 2) support or regeneration of vulnerable populations in neurodegenerative [e.g., amyotrophic lateral sclerosis (ALS), Heredi-Analyses indicate that endogenous NPCs do in fact contribute to transplantation-induced neuroprotection by influencing donor and mature tary Spastic Paraplegia and Primary Lateral sclerosis (HSP/PLS), Huntington's disease (HD), and Parkinson's disease (PD)] or acquired dis-host cell function in many ways. More specifically, with regards to neuroprotection, Ara-C-infused animals that were subsequently grafted ease [e.g., spinal cord injury (SCI)], to 3) enabling accurate models of neuron type-specific disease, to 4) identification of disease genes, and with NPCs performed significantly better on the cylinder task than sham controls, but were also significantly worse than NPC-grafted ani-to 5) attempts to functionally repair CNS circuitry. For example, data from our lab and others demonstrate that new neurons can be added mals that had received no prior Ara-C infusion. Stereological tyrosine hydroxylase (TH) cell counts through the substantia nigra support the to adult neocortical circuitry via manipulation of transplanted or endogenous precursors in situ [including induction of limited neurogen-behavioral data. With respect to graft behavior, it was observed that endogenous NPC inhibition altered the differentiation and growth fac-esis of clinically important corticospinal motor neurons (CSMN) in adult mice], indicating that cellular repair of cortical and cortical out-tor expression pattern of grafted NPCs. Also, the host immune response was perturbed in grafted animals lacking endogenous NPCs. put circuitry is possible, if controls over specific lineage differentiation are understood. Using fluorescence-activated cell sorting (FACS)-puri-Presently, we are investigating the roles of graft-expressed GDNF and SHH using RNA interference (RNAi) techniques. Specifically, NPCs fied CSMN and other neocortical projection neuron populations (including callosal projection neurons, corticothalamic projection neu-in which either GDNF or SHH, or both, have been silenced have been transplanted into host rats to determine whether or not they contribute rons, corticotectal projection neurons, and target-specific subsets of these populations) at critical stages of development in vivo, we identi-to the observed NPC-mediated neuroprotection and endogenous response to transplantation. Overall, our studies will help determine fied a broad set of combinatorially interacting developmental controls-both novel and largely uncharacterized transcriptional regula-some of the microenvironmental signals fundamental to the exogenous-endogenous stem cell synergism and neuroprotection, and will tors and other genes, and cell-extrinsic controls-that are instructive for development of specific neuron subtypes as they develop in vivo contribute towards the development of novel stem cell-based therapies for PD. (in particular, for CSMN, corticothalamic, callosal, and related projection neuron populations). These control key developmental processes . Our lab has §Iowa State University, Ames, IA, USA used this method in concert with a glutamate toxicity assay in cultured hippocampal neurons at 2 weeks in vitro. To date, we have tested the Current neural stem/precursor cell (NPC)-based therapeutic strategies for Parkinson's disease (PD) focus either on cell transplantation neuroprotective efficacy of the first four genes, transthyretin (TTR), thyrotropin releasing hormone (TRH), chemokine (C-C) motif ligand or endogenous cell stimulation. Future PD cell therapies most likely will involve combining these two approaches. Our previous studies in 7 (CCL7) and chemokine (C-C) motif ligand 2 (or monocyte chemotactic protein-1; CCL2) (Malik et al., 2010). Each protein protected at a 6-hydroxydopamine (6-OHDA) rat model of PD suggest a "synergy" between transplanted (exogenous) and endogenous NPC actions (Mad-a different concentration, and some exhibited a ceiling effect while others were not effective at higher doses. We have now completed the havan et al., J. Comp. Neurol, 2009; Madhavan et al., Neuropharmacology, 2010). In particular, our work demonstrated a significant en-cloning of 11 candidate neuroprotective genes into AAV backbones that also contains a green fluorescent protein (GFP) reporter gene. dogenous NPC response (proliferation, migration, and neurogenesis) to transplantation of exogenous NPCs prior to a 6-OHDA insult. These These 11 constructs have been screened for GFP expression in cell culture; all were positive, indicating the upstream genes of interest are events were associated with protection of the host nigrostriatal system along with amelioration of behavioral deficits (spontaneous paw place-also expressed. These AAV genome constructs are ready for packaging in the AAV1 capsid, which we previous identified as a highly ment in cylinder task). In addition, the transplanted NPCs expressed certain factors [glial-derived neurotrophic factor (GDNF), sonic hedge-neurotropic serotype of AAV (Royo et al., 2008). We will use these packaged vectors containing potentially neuroprotective genes in our hog (SHH), and stromal-derived factor 1α (SDF1α)], providing a potential molecular basis for the observed phenomenon. We have begun neuronal cell culture model for neurotoxicity and neuroprotection, before selecting the most efficacious ones for in vivo testing. These to investigate mechanisms underlying the phenomenon by examining genes identify new molecular cascades in TBI neuroprotection and be associated with synaptic vesicles and is thought to play a role in vesicle maintenance and neurotransmitter release. Paradoxically, α-syn hold the potential to be neuroprotective hours to days after TBI in humans.
knockout mice have revealed no overt pathogenesis. However, evidence exists for altered dopamine (DA) release, altered DA levels, and changes in DA vesicle number in these animals. Clinical and experimental data have shown that overexpression of wt or mutant α-syn The Effect of Preinjury Fitness Level on Prognosis and Clinical can induce PD-like neurodegeneration in humans and animals. This Outcome After a Single Moderate-to-Severe TBI:
has led to the suggestion that downregulation of α-syn might provide A Retrospective Case Study a therapeutic modality for synucleinopathies. However, recent data show that virally delivered short hairpin RNAs (shRNAs) targeting α-S. Malik,* S. Motamedi,* M. Paul,* T. T. Sitterley,* O. Bernal,* syn in the rodent substantia nigra result in significant dopaminergic S. Park, † E. Maloney,* and D. Watson* cell loss and resultant motor behaviors corresponding to levels of knockdown. In this project we sought to further characterize the ef-*Department of Neurosurgery, University of Pennsylvania, fects of α-syn knockdown in the rodent basal ganglia. Recombinant Philadelphia, PA, USA adeno-associated virus type 2/5 expressing either α-syn shRNA and †Department of Neurology, University of Pennsylvania, green fluorescent protein (GFP) as a transduction marker, or GFP Philadelphia, PA, USA alone, was stereotaxically injected in the substantia nigra (SN) or globus pallidus (GP) of adult rats. A subset of animals was sacrificed at 7 and 14 days following the injections. Histological analysis of these Clinical experience suggests that people with active lifestyles tend animals indicates the presence of apoptosis in the SNc of α-syn to recover better from traumatic brain injury (TBI) than more seden-shRNA-treated animals as early as 7 days following injection. In additary people. Surprisingly, however, there are no published studies tion, evaluation of low-dose amphetamine-induced rotational behavior about the effect of preinjury fitness level on prognosis or recovery in at later time points demonstrated significant contraversive behavior of humans after TBI. Our study aims to evaluate how the preinjury physianimals treated with α-syn shRNA in the SN, an indication of incal fitness level affects the clinical outcome after a single moderatecreased levels of cytosolic DA. However, high concentration amphetto-severe TBI. The enrollment of the subjects will be done through the amine rotational behavior resulted in significant ipsiversive behavior University of Pennsylvania Health System (UPHS) trauma and clinical of the SN-injected animals when compared to the GP group. Together, databases for consecutive patients who suffered a single moderate-tothese behavioral data indicates that the effect of α-syn shRNA is spesevere TBI over the course of the study and or during the past 1 year.
cific to the DA neurons of the SN. Our data, in concordance with Several data points, including the Glasgow Coma Scale (GCS), Acute previously published reports, agree with the fact that some level of α-Physiology and Chronic Health Evaluation (APACHE), Marshall syn is required for the survival of dopaminergic neurons, and is consis-Score, functional independence measure (FIM) on discharge, and tent with the hypothesis that loss of α-syn results in aberrant dopamine Modified Rankin Scale, Occupational/Physical Therapy (OT/PT) ashandling. sessment, will be extracted from the databases for preinjury fitness and postinjury outcome assessment. In addition to the retrospective chart review the patients and or the caregivers will be contacted telephonically and or via postal mail and asked a standard set of questions High Content Screening to Identify and Evaluate Remyelination [Physical activity questionnaire and activity measure for post acute Therapeutics for Multiple Sclerosis care (AMPAC)] to determine preinjury physical fitness and postinjury outcome. Informed consent will be obtained at the time of enrollment S. Medicetty,* C. Lego,* B. Bai,* G. Kidd,* † and B. Trapp* † either in person or through their caregivers during their initial hospital stay or via telephone if subject was identified from the database estab-*Renovo Neural Inc., Cleveland, OH, USA lished in the past year. The results of this study will help clinicians †Department of Neurosciences, Lerner Research Institute, advise their patients about prognosis, investigate the role (if any) of Cleveland Clinic Foundation, Cleveland, OH, USA preinjury fitness level on the recovery from TBI, and suggest molecular and biochemical pathways for future laboratory investigations and Multiple sclerosis (MS) is the most common inflammatory demyetranslational research.
linating disease of the central nervous system (CNS) and is the major cause of nontraumatic neurological disability in young adults in North America. Current MS therapies are anti-inflammatory or immunomo-rAAV-Mediated shRNA Knockdown of ␣-Synuclein in the Rat dulatory in nature, but these therapies are partially preventive (delay Substantia Nigra Results in Aberrant Dopamine Handling the disease progression) and not restorative. Replacement of oligodendrocytes and the subsequent remyelination of demyelinated axons have R. J. Mandel,* A. C. Rising,* T. Khundkar,* and F. P. Manfredsson † the potential to halt and reverse axonal loss and neurological decline. One approach to increasing remyelination is through therapeutic stim-*Neuroscience, University of Florida, Gainesville, Fl, USA ulation of endogenous oligodendrocyte progenitor cells (OPCs). This †Division of Translational Science & Molecular Medicine, Michigan approach is feasible because generation of new oligodendrocytes and State University College of Human Medicine, Grand Rapids, MI, USA spontaneous remyelination occur in many MS lesions during early stages of the disease, and even in some chronic lesions, although endogenous remyelination eventually fails. The hypothesis is that small Parkinson's disease (PD) is a relatively common progressive neurodegenerative disorder generally affecting the aging population. PD molecules can be used as therapeutic agents to stimulate differentiation of oligodendrocytes and promote endogenous remyelination. Two re-patients generally present with unilateral motor symptoms, such as resting tremor, which progresses bilaterally over time with increasing cent technological developments enable the identification and evaluation of such small molecules. First, we have developed a standard op-severity. Motor symptoms arise from the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) re-erating protocol to generate a relatively homogeneous (>85% pure) and consistent population of OPCs that can be used as a reliable start-sulting in the loss of dopaminergic innervation in the terminal fields of the caudate/putamen. Although a majority of PD cases are sporadic, ing material for high-content and relatively high-throughput screening. Second, we developed a high-content and relatively high-throughput several familial forms of PD have been identified. α-Synuclein (αsyn) was the first such gene to be identified where it was shown that cell-based phenotypic screening method that can automate identification and analysis of differentiated cells in these cultures. The pheno-different mutations in the encoding gene results in PD. α-syn is an abundant protein in the CNS, which has been associated with the typic screen is employed in two phases: primary screen to identify potential candidates that promote OPC differentiation based on cell pathogenesis of several neurodegenerative disorders. Although the function of α-syn is largely unknown, the protein has been shown to morphology, and secondary screen to confirm and qualify compounds by immunocytochemical staining for oligodendrocyte-specific mark-The Evolution of Alzheimer's Disease: Neuroplastic and Neurodegenerative Changes Within the Human ers. A set of compounds was used to validate this approach. Ciliary neurotrophic factor (CNTF), which is known to promote OPC differ-Cortical Connectome entiation, has been identified by the primary screen and later qualified by the secondary screen (O4-positive The neuronal "connectome" represents the network of elements Primary respiratory drive arises from neurons within the ventral and connections underlying the neurostructural substrate of cognition respiratory column (VRC) of the medulla. The VRC is comprised of and memory. Disruption or reduction of the connectome (e.g., changes neurons within the Bö complex, pre-Bö complex, rostral ventral respiin dendritic branching and/or spines) appears to play a key role in the ratory group (rVRG), and caudal VRG (cVRG). The rVRG and cVRG onset and progression of dementia. Mild cognitive impairment (MCI), innervate respiratory spinal motoneurons controlling inspiratory and which is associated with subtle memory loss, is regarded as a prodroexpiratory activity, respectively. Whether this supraspinal respiratory mal stage in the development of Alzheimer's disease (AD). Here we organization changes following cervical spinal cord injury (SCI) is characterized, first, the earliest alterations in the cortical connectome unknown. Given the extent of reorganization of supraspinal activity associated with MCI, and secondly, additional connectome changes (e.g., cortical) that has been reported following SCI, we hypothesized associated with the progression of MCI into frank AD. Connectome that a high cervical lateralized hemisection (C2Hx) will result in reorchanges were compared from three cortical regions: the inferior pariganization of respiratory activity in the medulla. The present study etal cortex (Brodman areas 39, 40), the inferior temporal cortex (area used stereotaxic coordinates and neurophysiological recordings for 21), and the superior frontal cortex (area 9). Formalin-fixed tissue mapping the distribution of neurons active during either inspiratory or blocks were harvested from individuals diagnosed as noncognitively expiratory phases of spontaneous breathing in anesthetized, adult feimpaired (NCI), MCI, or AD. The blocks were Golgi impregnated and male Sprague-Dawley rats. Electrophysiological recordings from norcoded slides prepared for analysis of branching and spines. Assessmal (uninjured) animals were compared with animals 12 weeks folment of randomly selected layer II-III pyramids from the three diaglowing C2Hx. Once anesthetized the dorsal surface of the caudal brain nostic categories and the three cortical brain regions showed that neustem was surgically exposed. Extracellular recordings within the merons from both parietal and temporal cortices displayed a comparable dulla were then made at multiple locations 200 µm apart, using a grid loss of connectome circuitry: ϳ−30% and −50% in MCI and AD, repattern, and at depths ϳ500 µm apart from the dorsal surface of the spectively. However, in the frontal cortex, in MCI there is a massive medulla. The phasic respiratory activity was amplified and passed neuroplastic enhancement in branching and spines that amounts to a through an audio monitor, and digitized for Spike2 software on a PC 75% increase in the connectome for these neurons. In the subsequent computer, to correlate activity with the animals observed breathing progression from MCI to AD, there is a 68% reduction of the connectpattern. 3D maps of inspiratory and expiratory activity for each animal ome in the frontal cortex. These results indicate that in the evolution were created using Adobe Illustrator. Preliminary results have revealed of AD, layer II-III neurons of the temporal and parietal regions una dramatic shift in the pattern of inspiratory and expiratory activity dergo a progressive loss of branching and spines, initially in MCI and, following injury. The number of sites at which inspiratory activity additionally, in AD. However, by contrast, neurons in the frontal corcould be located was reduced. In contrast, expiratory phase activity tex show an initial neuroplastic response in MCI. This could be a was now more widely detected and was frequently observed within compensatory mechanism-unique to the frontal cortex-which is the regions normally shown to have inspiratory phase activity. Neurohelping to maintain circuitry and minimize cognitive dysfunction beanatomical studies are being pursued to visualize the distribution of fore being overwhelmed by the subsequent further progression of AD. neurons with inspiratory versus expiratory activity. What role the It also suggests that if the molecular mechanisms associated with the expansion of expiratory phase activity may play in postinjury breathneuroplasticity seen in the frontal cortex in MCI can be identified, ing function remains undefined at present, but the decreased number they may provide a unique prophylactic or therapeutic approach to of cells active during the inspiratory phase may limit the potential for prevent, minimize, or reverse the loss of the neuronal networks associrecovery of inspiratory drive following SCI. ated with AD-related cognitive dysfunction.
Supported by AG14449 and The Honors College of the University of South Florida.
Preclinical Efficacy Testing of a Human Neural Stem Cell Line
is a neuronally derived signal that has been shown to regulate the neurotoxic effects of microglia though its receptor CX3CR1. Disrup-(CTX0E03) in a Rat Model of Stroke tion of FKN-CX3CR1 signaling has been shown to exacerbate neurotoxicity in animal models of many neuropathological disorders, includ-M. Modo,* E. Smith,* † R. P. Stroemer, † N. Gorenkova,* ing AD. In the present study we investigated if chronic inflammation L. Stevanato, † E. Tang, † and J. Sinden † alters neuron-microglia signaling via the FKN-CX3CR1 signaling pathway. Rats (n = 6) were chronically infused for 28 days with LPS *King's College London, London, UK (0.25 µg/h) or artificial cerebrospinal fluid (aCSF, n = 6). On day †ReNeuron Ltd., Guildford, UK 29-31 animals where tested for novel object and novel place recognition. LPS-induced chronic neuroinflammation resulted in impairment Stroke causes severe neurological deficits. Transplanting human of hippocampus-dependent novel place recognition but not of hipponeural stem cells can alleviate some of these deficits. We here comcampus-independent novel object recognition. Analysis of hippocampared the effect of intraparenchymal and intraventricular grafts pus protein lysates revealed no significant changes in FKN levels be-(450,000 CTX0E03 cells) in a rat model of stroke, on behavioral retween aCSF-or LPS-infused animals. Interestingly, there was a covery and in vivo anatomical changes by MRI, as well as histological significant reduction in the amount of CX3CR1 protein levels in LPScorrelates. Intraparenchymal, but not intraventricular, CTX0E03 iminfused animals compared to aCSF controls. The LPS-induced reducplants recovered deficits on the bilateral asymmetry test, the foot fault tion in CX3CR1 paralleled a significant induction of the proinflammatest, amphetamine-induced rotations, but no improvement was obtory enzyme phospho-p38 mitogen-activated protein kinase (pp38 served in the water maze. Serial T2-weighted MRI (pre, 1, 4, 12 MAPK). These results suggest that FKN/CX3CR1 signaling is inweeks) did not exhibit any significant anatomical changes. Only anivolved in the modulation of LPS-induced chronic neuroinflammation. mals with intraparenchymal grafts had a mean graft survival of 10,000
The FKN/CX3CR1 signaling pathway may mediate the altered coucells, although two animals (out of 15) did not have any cells survivpling of neuronal activity with macromolecular synthesis implicated ing. These stereological results were corroborated by Alu-PCR. Surin plasticity and memory (Arc expression) during LPS-induced neuvival was correlated with the spread of cells, the volume of the graft, roinflammation, further studies are ongoing to test this hypothesis. and the density of the graft. However, there was no correlation be- through mechanisms involving oxidative stress. We have found that in of California San Francisco, San Francisco, CA, USA young monkeys DA neurons are markedly resistant to either metham- ‡James A. Haley VAMC, Research Service, Tampa, FL, USA phetamine or MPTP. Methamphetamine or MPTP reduced striatal DA concentration and tyrosine hydroxylase expression (by 70-95%) in adults, while causing no significant loss of either measure in young Neuroinflammation is associated with a variety of neurological and pathological conditions, such as Alzheimer's disease (AD) but also monkeys. Altered pharmacokinetics do not provide an explanation for these differences, as the same dose of methamphetamine results in normal aging, and is reliably detected by the presence of activated microglia, the resident immune cells of the brain. AD is characterized higher striatal and plasma drug levels in the young, compared with the adult, monkey. We are examining mechanisms that would provide an by progressive memory loss and cognitive dysfunction and it is due, in part, to a deficit in synaptic plasticity that precedes the neurodegen-explanation for the resistance of young monkeys to methamphetamine and MPTP, as this may shed light on the plasticity and regenerative erative changes; this early deficit may be exacerbated by activated microglia. Activated microglia and their products are key mediators of capacity of the DA system at different stages of primate development, and provide targets to enable the early-in-life protection from damage neuroinflammation and contribute to neuronal damage. In early AD, before neuronal loss occurs, the highest numbers of activated microg-to DA neurons to be reinstated later in life. Oxidation of cell-permeable dihydroethidium (DHE) to red fluorescent cell-impermeable lia are observed in the hippocampus and entorhinal cortex. Neuroinflammation can be reproduced by chronically infusing lipopolysaccha-ethidium provides a way to detect intracellular reactive oxygen species (ROS). Following injection of DHE very little ethidium was observed ride (LPS) into the fourth ventricle of rats, resulting in region-selective microglia activation in the hippocampus, elevated tumor necrosis fac-in the young nigrostriatal system, compared with the adult striatum, indicating a relative lack of ongoing ROS formation in the younger tor-α (TNF-α) and interleukin-1β (IL-1β), and impaired hippocampaldependent functions. Furthermore, this treatment results in altered ex-brain. This low background of oxidative stress may contribute to the protection from oxidative stress elicited by methamphetamine or pression of the plasticity-related behaviorally induced immediate early gene Arc only within these regions showing activated microglia, sug-MPTP. Elevated production of the neurotrophic factor, glial-derived neurotrophic factor (GDNF), is a potential mechanism that developing gesting altered network activity. Recent findings indicate that neurons are not passive targets, but rather control microglial activity and modu-DA neurons could utilize to avoid the toxic effects of methamphetamine. Young monkeys demonstrated a 2.5-fold increase in striatal late neuron-glia communications. The chemokine fractalkine (FKN) 576 ABSTRACTS GDNF after exposure to methamphetamine. Untreated adult monkeys were observed in Cu-and Ag-treated but not in Al-treated rats. The number of dark and distorted neurons in various brain regions was had a similar level of striatal GDNF as untreated infant monkeys. The same treatment with methamphetamine did not, however, result in any significantly increased in Cu-and Ag-treated but not in Al-treated rats. A significant increase in the number of nNOS positive neurons was change in striatal levels of GDNF in the adult. The ability of the young brain to induce overexpression of GDNF in response to oxidative seen in the cortex, hippocampus, cerebellum, thalamus, and hypothalamus in these nanoparticle-treated rats compared to normal rats. Inter-stress could mitigate the toxic effect of methamphetamine. Uncoupling proteins (UCPs) are mitochondrial membrane proteins that regulate estingly, the occurrence of nNOS-positive neurons was seen into areas showing BBB disruptions to Evans blue. Intravenous administration ROS production, so a differential expression of UCPs is another potential mechanism that might protect developing DA neurons. A signifi-of insulin like growth factor-1 (IGF-1) in high doses (1 µg/kg, once daily for 7 days) commenced at the same time as nanoparticle adminis-cant twofold higher expression of UCP-2 mRNA occurred in substantia nigra of young compared with adult monkeys, suggesting that this tration, significantly reduced the oxidative stress parameters and nNOS upregulation. The cell changes and the BBB breakdown caused might be a protective mechanism in the developing DA system that is suppressed later in life. Our recent work (Andrews et al., J. Neurosci.
by the nanoparticles were also considerably reduced. Taken together these novel observations demonstrate that nanoparticles, depending on 29:14057-14065, 2009) has shown that the hormone, ghrelin, protects against MPTP toxicity by a UCP-2-dependent mechanism. Thus, their type (Cu and Ag and but not Al), are able to induce severe oxidative stress and nNOS expression, leading to BBB disruption and cell ghrelin may be a novel UCP-dependent strategy to reduce DA neurodegeneration that is associated with PD and aging.
injury. Furthermore, IGF-1 has profound neuroprotective effects on nanoparticle-induced brain damage, not reported earlier. Stroke with high incidence in the elderly is a leading cause of long-term disability worldwide. Currently, there is no treatment avail-The possibility that chronic exposure of nanoparticles leads to breakdown of the blood-brain barrier (BBB) and brain pathology by able for chronic stroke other than physical therapy. We have recently demonstrated the therapeutic effects of two hematopoietic growth fac-inducing oxidative stress and increased nitric oxide production was examined in a rat model using biochemical and morphological ap-tors, stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF), in animal models of chronic stroke. However, the mecha-proaches. Separate groups of rats (male Sprague-Dawley, body weight 200-250 g, age 18-22 weeks old) were treated with silver (Ag), cop-nisms underlying SCF + G-CSF-induced functional improvement during chronic stroke remain to be explored. Neural network remodeling per (Cu), or aluminium (Al) nanoparticles (50 mg/kg, IP) once daily for 7 days, whereas, the control group received saline under identical including apical dendritic spinogenesis of pyramidal neurons in the peri-infarct cortex has been thought to play a critical role in functional conditions. These rats were tested on the 8th day for sensory and cognitive dysfunction using Rota rod performance, grid walking, inclined recovery after stroke. Here we aimed to determine the effects of SCF + G-CSF in apical dendritic spinogenesis in a mouse model of chronic plane angle tests, and stride length test using standard procedures. After that the BBB permeability was measured using Evans blue albu-stroke. Aged male transgenic mice (16-18 months old) genetically expressing yellow fluorescent protein (YFP) in the layer V pyramidal min and radioiodine tracers in several brain areas. Brain edema formation was examined by measuring brain water content, and oxidative neurons were subjected to cortical brain ischemia through permanent occlusions of the right common carotid artery and middle cerebral ar-stress parameters were determined using brain oxidants levels [e.g., myeloperoxidase (MP), malondialdehyde (MD), and glutathione (GT) tery. Four to 5 months after induction of brain ischemia, mice were randomized to receive subcutaneous injection of saline or SCF + G-were measured in various brain regions]. Using immunohistological methods, upregulation of neuronal nitric oxide synthase (nNOS) im-CSF for 7 days. Two thinned skull windows (ϳ200 µm in diameter) were produced adjacent to the infarct cavities before starting treatment. munoreactivity was examined on paraffin sections under light microscope. In these serial sections, cell changes were seen at light micros-Live imaging of the apical dendritic spines of layer V pyramidal neurons in layer I/II was acquired with a Zeiss multiphoton microscope copy using Nissl or hematoxylin and eosin. Rats treated with Cu and Ag nanoparticles exhibited mild to moderate sensory motor dysfunc-(920 nm to excite YFP) through the thinned skull windows before treatment or 2 weeks after the final injection. High-resolution image tion as seen by reduction in time for staying on the Rota rod (16 rpm, 120 s to 80 s), decline in the angle of inclined plane (from 60°to 40°), stacks were taken 20 µm deep from the brain surface with 1-µm intervals. Live brain imaging data revealed that the number of dendritic placement error of forepaws during grid walking (from 0% to 34%), and increase in stride length between two hind limbs while walking spines was not different between the two groups before starting treatment. However, significant increases in the number of the thin or (from 45 to 85 mm). These changes were only mildly affected by Al treatment. We observed a significant increase in MP and MD levels mushroom-like spines on the dendrites were observed in SCF + G-CSF-treated mice 2 weeks after treatment. These data suggest that SCF (MP 4 ± 1 to 9 ± 2 U/g, p < 0.01; MD 24 ± 4 to 56 ± 8 nM/g, p < 0.01) in the brains of Cu-and Ag-treated rats, whereas, GH showed a + G-CSF can enhance neural network remodeling in the aged brain of chronic stroke. This study provides new insights into the role of significant decline (from 1.8 ± 0.04 to 0.8 ± 0.04 µM/g, p < 0.01) in Cu-and Ag-treated rats. Changes in Al treatment were not significant hematopoietic growth factors in brain repair during chronic stroke and would aid in developing a new therapeutic strategy for chronic stroke. in any of these oxidative stress parameters. A significant increase in brain water and BBB breakdown to Evans blue and radioiodine tracers This work was supported by NIH NINDS R01 NS060911.
Effect of a HDAC Inhibitor on Neural Stem Cell Regulation
weeks postinjury, which were sustained for at least 6 weeks in controlinjected animals. Compared with the control injection group, mechani-and its Application to Spinal Cord Injury cal and cold allodynia were reduced significantly by recombinant analgesic peptides. The injection of lenti-EM1, lenti-EM2, or the SHG/ K. Nakashima EM1/EM2 combination resulted in reduced neuropathic pain lasting at least 1 month after injection. The antinociceptive effects of EM1 or Laboratory of Neuroscience, Graduate School of Biological Sciences, EM2 alone were comparable to the mixture. Intrathecal injection of Nara Institute of Science and Technology, Ikoma Nara, Japan naloxone reversed the antiallodynic effects of the lenti-EMs, and both naloxone and the anti-SHG antibody attenuated cold allodynia in ani-Neural stem cells (NSCs) possess the ability to self-renew and to mals receiving the mixed vectors. In conclusion, intraspinal adminisdifferentiate into the three major cell types found in the central nertration of recombinant constructs encoding EMs and SHG can produce vous system (CNS): neurons, astrocytes, and oligodendrocytes. Recent significant analgesic effects on neuropathic pain after SCI in rats and studies have shown that epigenetic gene regulation events such as suggests a promising therapeutic approach in the management of in-DNA methylation and histone modification play important roles in tractable clinical SCI pain. regulating NSC fate specification. In this context, we have previously Biology, Umeå University, Umeå, Sweden tract tracing revealed that transplant-derived neurons partially recon- †Department of Experimental Medical Sciences, Neurobiology, structed the broken neuronal circuits, most likely in a "relay" manner.
Lund University, Lund, Sweden Ablation of the transplanted cells abolished the recovery of hind limb motor function, indicating that transplanted cells contributed directly
The symptoms of Parkinson's disease are pharmacologically counto the improvement of motor function. These data raise the possibility teracted with levodopa to increase the striatal dopamine levels. Unforthat epigenetic regulation in transplanted neural stem cells can be extunately, long-term treatment causes levodopa-induced dyskinesia in ploited to provide treatment for SCI.
the majority of patients. Levodopa-derived dopamine release from the serotonergic neurons has been pointed out as the main contributing factor for the onset of dyskinesia. At present, several studies indicate
Use of Viral Vectors Encoding Endomorphins and Histogranin
that apart from uncontrolled dopamine signaling, increased corticostrifor Pain Alleviation in a Rodent Spinal Cord Injury Model atal glutamate transmission may contribute to the pathophysiology of dyskinesia. Therefore, in the present study, in vivo amperometry was F. Nasirinezhad, J. Vasquez, M. Diaz, S. Gajavelli, and J. Sagen employed to study glutamate release in the striatum of chronically levodopa-treated dyskinetic and normal rats. Glutamate release was potassium evoked before and after local levodopa administration in anes-Pope Life Center, Miami Project to Cure Paralysis, University thetized animals, and the response was monitored second-by-second of Miami, Miami, FL, USA with electrodes highly selective for glutamate. Hence, it was possible to observe how long-term levodopa treatment and acute application of Pain is a frequent consequence of spinal cord injury (SCI), which the drug affect the extracellular glutamate release and reuptake. In the profoundly impairs the patient's quality of life. SCI pain is clinically normal levodopa-naive striatum, the amplitude of potassium-evoked difficult to treat and, despite many decades of drug development, efglutamate release was 20-30 µM, which was sustained upon levodopa fective therapies still remain elusive. Ionotropic glutamate receptors loading. In the chronically levodopa-treated dyskinetic animals, glutacontribute to maintained pain following damage to the nervous system mate release was significantly reduced to approximately 5 µM, and it in rats. Serine-histogranin (SHG) is a synthetic 15-amino acid peptide was further attenuated after local levodopa administration. This was that exhibits N-methyl-D-aspartate (NMDA) receptor antagonist activseen in both the dopamine-lesioned and intact striatum of dyskinetic ity. Previous studies in our lab showed that intrathecal coadministraanimals, thus not affected by the presence of dopaminergic nerve fition of m-opioid peptide receptor agonists, endomorphins and SHG, bers. Furthermore, the levodopa injection itself provoked a glutamate resulted in robust antinociceptive effects in SCI rats. Because continurelease in all animals, regardless of treatment. This release was sevous administration of pharmacological agents is often associated with eral-fold higher than the potassium-evoked glutamate release. To conundesirable side effects, the aim of this experiment was to investigate clude, chronic levodopa treatment seems to depress the glutamate rethe recombinant potential of these genes in an SCI neuropathic pain lease in dyskinetic animals, possibly due to elevated basal extracellular model. In order to accomplish this, lentiviruses that encode endomorglutamate levels. phins 1 and 2 (EM1 and EM2) and SHG were generated. SCI pain was produced by clip compression of the spinal cord at the level of T6-T8. Rats were randomly assigned to different treatment groups with a minimum of eight rats per group. At 2 weeks following SCI, Validating Exogenous Markers of Transplanted Cells separate groups of animals received intraspinal injections of lenti-EM1, lenti-EM2, mixed SHG/EM1/EM2 (3:1:1 ratio), or control vec-F. Nicholls,* E. Bible,* C. Hicks, † C. M. Tolias, ‡ and M. Modo* tor. Injections were made stereotaxically into the dorsal horn at the lumbar enlargement in order to target below-level SCI pain. Animals *Department of Neuroscience, King's College London, London, UK were tested for heat hyperalgesia and mechanical and cold allodynia †ReNeuron Ltd, Guildford, UK using the Hargreaves method, Von frey filament, and acetone tests, ‡Department of Neurosurgery, King's College Hospital, London, UK respectively. At the end of the experiment, the contribution of EMs and SHG to analgesic effects was assessed by intrathecal injection of either opioid antagonist naloxone or anti-SHG antibody, respectively. Postmortem evaluation relies on being able to identify transplanted cells within the host brain, weeks and potentially years after transplan-Clip compression SCI resulted in neuropathic pain symptoms by 2 578 ABSTRACTS tation. Bromodeoxyuridine (BrdU), PKH26, and Hoechst are often identifying for the first time a mechanism necessary for the active maintenance of commitment in adult neurogenesis. used to label cells, but their validity and reliability to unequivocally identify transplanted cells is potentially compromised due to label transfer from grafted to host cells. Labels were assessed in vitro to analyze their labeling efficiency of human neural stem cells (hNSC), Exposure to the Peripheral Toxin MPP + Enhances as well as their effects on viability, proliferation, maintenance of NSC MPTP-Induced Dopamine Neuron Loss and Neuroinflammation markers, and differentiation towards neural and glial lineages. Hoechst and PKH26 efficiently labeled cells in vitro, with BrdU being the low-A. Patel,* K. Colletta,* G. V. Toia,* P. Carvey,* † and B. Hendy* est, at ϳ90%. However, all three affected cell proliferation. To establish the temporal evolution of the reliability of these markers in vivo, *Department of Pharmacology, Rush University, Chicago, IL, USA hNSC were grafted into rat brains and postmortem analyses were con- †Department of Neurological Science, Rush University, ducted at 1, 7, 28, and 64 days posttransplantation. The label was Chicago, IL, USA assessed on the extent to which it colocalized with specific endogenous markers of human cells, such as human nuclear antigen (HNA) and Y chromosome. The total number of cells identified by each label Our laboratory has shown that different dopamine (DA) neurotoxins [1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP), 6-hydrox-was also compared to Alu-PCR. BrdU labeling was generally colocalized with HNA, although at day 7, there were also a large number of ydopamine, rotenone, and lipopolysaccharide] produce blood-brain barrier (BBB) disruption in DA-rich regions such as the substantia HNA − /BrdU + cells. This suggests a potential label transfer to host cells, and thereby an overestimation of the total number of trans-nigra (SN) and striatum. Areas of BBB leakage colocalized with β3 integrin expression, a marker of angiogenesis. This finding was not planted cells. In contrast, at 64 days, reliance on BrdU as the sole indicator of transplanted cells would have led to an underestimation surprising as newly created angiogenic vessels are often leaky and are unlikely to have a fully developed BBB. We have also found evidence of transplanted cells. Finding a reliable marker to detect transplanted cells is paramount to assessing the neurobiological basis of their effi-of αvβ3 integrin expression in postmortem human brain tissues from patients with Parkinson's disease, suggesting ongoing angiogenesis cacy. This might not only depend on their labeling efficiency, but also their effect on cell viability, proliferation, differentiation, and retention and BBB compromise. We propose that a dysfunctional BBB would allow entry of peripheral toxins that further contribute to DA neuron of the label within transplanted cells in vivo. 2010) . However, the molecular mechanisms of how Pax6 endows cells with a neurogenic fate are still elusive. Here we show that Brg1, limited to animals previously treated with MPTP. These results are consistent with the hypothesis that MPTP induces BBB dysfunction an ATP-dependent chromatin remodeling factor, is required for the neurogenic fate maintenance. In the absence of Brg1 function, adult-that then allows peripheral toxins to enter the parenchyma and enhance inflammation and DA neuron loss. Ongoing studies using longer pro-generated neuroblasts convert to glial cells expressing the hallmarks of glial progenitors such as NG2 and Olig2. We further showed that tocols and multiple exposures to MPP + will determine if soluble toxins can induce a progressive loss of DA neurons in the MPTP mouse Brg1 directly interacts with Pax6 in the migrating neuroblasts at the late stage of their differentiation. Similar to Brg1 loss-of-function, model. Supported by the Kenneth Douglass Foundation and NINDS R01-the loss of Pax6 in neuroblasts, even when already migrating along the rostral migratory stream (RMS) towards the OB, results in the fate N5052414. conversion of these neuroblasts towards an NG2 + glia fate. Interestingly, Pax6 expression is not altered in the Brg1 mutant and Pax6 cannot mediate neurogenesis in the absence of Brg1. These data suggest that Brg1 and Pax6 form a functional complex necessary for the maintenance of neuroblast fate in the adult RMS. We shall further present data demonstrating a transient role of this complex in neuronal differentiation, as this complex is no longer needed in mature OB neurons, such as the dopaminergic periglomerular neurons that do not alter their identify upon loss of either Pax6 or Brg1. In summary, our data reveal the functional complex of the transcription factor Pax6 with the Brg1-containing chromatin remodeling machinery as a key mechanism to maintain neuronal fate in migrating neuroblasts, thereby ciated with immune suppression. There was no case of graft over-Freiburg, Germany growth. One patient deteriorated closely after withdrawal of immune suppression and improved after administration of high-dose steroids. Detailed analysis of the composition of neural precursors for cell By assessing functional parameters, the clinical course after transplantransplantation is a critical process because contamination of cells tation was assessed. While cognitive parameters showed a slight worsfrom other brain regions is undesirable and might mitigate the funcening initially after transplantation and a slow improvement, individtional benefits. Here we report the establishment of a marker-based ual patients had marked stabilization of cognitive parameters and other map that allows the analysis of the composition and developmental parameters continued to deteriorate. Different types of clinical develage of cultured neural precursors by using immunocytochemistry. E14 opments have also been identified when regarding the motoric part of rat embryos as well as human fetuses between the 6th and 11th week the HD rating scale. Clinical WGE transplantation in HD has been of pregnancy were dissected into cortex (dorsal telencephalon), whole shown to be generally safe and feasible, contrasting with results from ganglionic eminence (WGE; ventral telencephalon), diencephalon, solid organ transplantation. The potential immunogenicity of the grafts ventral mesencephalon (VM), dorsal mesencephalon (tectum), and and the ongoing degeneration of the host brain might inhibit more rhombencephalon (hindbrain). Cells were enzymatically dissociated substantial clinical beneficial effects in the long-term course of the and cultured under differentiation conditions for 24 h and 7 days. Afdisease. Our data indicate general safety and promote further refineterwards wells were processed for immunocytochemistry, using fetal ments of the method and upcoming trials using alternative cell rebrain region-specific transcription factors to analyze neural precursors sources in HD. However, the complete evaluation of the mutlicenter and neurotransmitter phenotype-associated markers to analyze mature MIG-HD trial will help gain substantial information on the effectiveneurons. In addition, well-characterized glial and general neuronal ness of this method. markers as well as markers of the VM and WGE were used. We identified markers for the fetal and adult cortex, WGE, thalamus, and VM Phase I/II Randomized Controlled Trial of Autologous Bone and hindbrain that did not cross-stain with other brain regions, or their Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic expression patterns clearly differed from the profile in other regions.
Generation of an Age-and Region-Specific
Intracranial Hemorrhagic Stroke Additionally, tissue inclusions from adjacent brain regions of the target region can now be identified with certainty. Extension of this marker W. S. Poon,* S. C. P. Ng,* K. S. Tsang, † X. L. Zhu,* G. Lu,* tool for the application on human fetal neural precursors is currently D. Yeung, ‡ G. K. C. Wong,* D. T. F. Sun,* A. Ahuja, ‡ in progress, but the data are comparable with the results obtained from and H. K. Ng † fetal rat tissue. In summary, we established a set of markers to analyze differentiation stage and region specificity of cultured rodent and hu-*Department of Surgery, Prince of Wales Hospital, The Chinese man neural precursors, which will provide an essential tool in future applications of cell-based therapies in clinical thase. PEMF therapy has demonstrated anti-inflammatory properties While some atypical development occurs in the fetal period, much of through its ability to attenuate postsurgical inflammatory cytokine exthe aberrant development associated with DS occurs in largely postnapression. Interleukin-1β (IL-1β) is an inflammatory cytokine and imtally developing structures, such as the hippocampus. Thus, the brain portant mediator of the body's immunologic and systemic response to provides a "window of opportunity" for intervention. Recent successinjury, especially in the context of TBI. Similar to UCH-L1, the degree ful outcomes in the application of neural progenitor cells (NPC) for of IL-1β expression after head injury has been shown to correlate with other neurodegenerative disorders indicate that their application in DS the severity of TBI. In this study, we report the ability of PEMF thermay be a viable option by preventing or ameliorating the postnatal apy to reduce IL-1β expression and microglial activation after invasive degenerative changes and aberrant development. Additionally, the and noninvasive TBI. The effects of PEMF on TBI-induced inflammaneonatal brain may be uniquely equipped to accept and be influenced tion and neurodegeneration were investigated in an animal model. by implanted NPC due to endogenous cues present at this stage of Adult Sprague-Dawley rats were subjected to a 4-Newton head impact development. To explore the feasibility of early postnatal treatment in and analyzed for IL-1β expression 6-7 h later via enzyme-linked ima mouse model of DS, we bilaterally implanted 100,000 C17.2 murine munosorbent assay (ELISA) of brain homogenates and CSF. A second NPC (mNPC) into the dorsal hippocampus of postnatal day 2 (PND cohort of rats was subjected to a bilateral, invasive stab injury, and 2) Ts65Dn pups. This immortalized cell line is labeled with green similarly analyzed for IL-1β expression over the course of 5 days. fluorescent protein (GFP) and lacZ for identification after implant. Di-Histopathologic evidence of microglial infiltration and astrogliosis was somic littermates provided karyotype controls for DS modeling trisoobtained by immunostaining for CD11b and glial fibrillary acidic promic pups. Control litters were either not treated or sham implanted tein. UCH-L1 was characterized with Western blot analysis. PEMF with saline. The implanted C17.2 mNPC had robust survival and had treatment was associated with a 30-40% reduction in IL-1β levels widely migrated 7 days after implantation. In addition to mNPC found compared to control (p < 0.05) in CSF and brain homogenates for both at the hippocampal site of implantation, cells were found to have mitypes of injury. PEMF signals also appeared to decrease histopathograted to the somatosensory cortex and to the hypothalamic area surlogic evidence of microglial infiltration and astrogliosis in the invarounding the third ventricle. Analysis of long-term migration and sursive-injury group compared to control. Taken together, results suggest vival of implanted mNPC revealed that at 16 weeks of age, 8 of 14 that PEMF therapy can attenuate molecular and cellular inflammation (57%) of the trisomic mice and 50% of the disomic mice had positive after TBI. Because inflammation is directly related to edema and sub-GFP-labeled mNPC. However, the number of surviving cells was sequent neuronal loss, we predict that this modality will reduce mortalsmall and primarily limited to the hippocampus in both karyotypes.
ity and neurological deficits. mNPC were found as granule cells in the dentate gyrus, in the pyramidal cell layer of Ca1 and Ca3, and in the oriens and molecular layer and morphologically appeared to be interneurons. No needle track was Effect of Spinal Cord Tissue Preservation by Bone Marrow observed as a result of the implantation procedure in either karyotype.
Stromal Cells on Functional Recovery After Spinal Cord
Long-term implanted cell survival varied greatly even within litters, Contusion in Rats: More Is Better as often littermates that received the same cell preparation had widely variable mNPC survival. Overall, the number of implanted cells found in adult animals was low and did not affect the density of cells found G. J. Ritfeld,* † K. Vajn,* R. A. C. Roos, † and M. Oudega* ‡ in the dentate gyrus, which showed no significant difference between any group (p > 0.05). This study confirms that implanted mNPC can *Department of Physical Medicine & Rehabilitation, University survive and migrate in the trisomic environment present in DS. While of Pittsburgh School of Medicine, Pittsburgh, PA, USA the implanted mNPC can migrate from the hippocampal site of im- †Department of Neurology, Leiden University Medical Center, plantation, long-term cell survival appears to be limited to this region, Leiden, The Netherlands which is preferentially compromised in DS. Future studies will focus ‡Department of Neurobiology, University of Pittsburgh School on the potential ability of these cells to prevent age associated tau of Medicine, Pittsburgh, PA, USA accumulations and behavioral degenerative changes found in these mice.
In a rat model of spinal cord injury, the effects of an allogeneic This work was supported by a NINDS pre-doctoral Ruth L. Kirbone marrow stromal cell (BMSC) graft on hind limb locomotor and schstein National Research Service Award (NRSA) F31NS060517 and sensory function and on tissue volume and axon numbers were investithe Anna and John J. Sie Foundation.
gated. The T9 spinal cord was contused using the Infinite Horizon Impactor at a force of 200 kdyn(e) and injected 3 days later with 5 µl DMEM with 1 × 10 6 BMSCs or DMEM alone into the injury epicen-ter. Two months after BMSC transplantation, rats exhibited a fourfold observations. This extensive vascular basement membrane collagen accumulation in ALS patients suggests impairment of capillary endo-increase in Basso, Beattie and Bresnahan (BBB) subscore, a 26% smaller angle of hind paw rotation, and a 70% improvement on the thelium integrity, probably leading to BBSCB dysfunction in ALS as a major pathophysiological mechanism. Furthermore, it is possible that horizontal ladder compared to controls. Also, rats with a BMSC transplant exhibited a 52% decrease in mechanical allodynia and a 25% abnormal buildup of basement membrane collagen alters barrier transport functions and thus impairs CNS homeostasis in ALS. Although decrease in thermal allodynia compared to controls. BMSC transplantation resulted in a 66% increase in spared tissue volume compared to the mechanism(s) of basement membrane collagen accumulation is unclear, we hypothesize that the vascular basement membrane collagen controls. Correlative analysis revealed that larger volumes of intact spinal cord tissue corresponded with better motor and sensory function increase in ALS results from a metalloproteinase/inhibitor imbalance. Currently, we are investigating this possibility. outcomes. The number of serotonergic and catecholaminergic axons caudal to the contusion was similar in both groups. BMSC-treated ani-Supported by the Muscular Dystrophy Association. mals showed increased numbers of fast blue back-labeled brain stem neurons with extensions caudal to the injury site. JCMM, 2009 ) suggested that reducing the number of cell passages may increase transplant survivability in rats and increase their efficacy in reducing behavioral deficits in the 3-nitropropi-Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor neurons in the brain and onic acid rat model of HD (Rossignol et al., BBR, 2010). The two major goals of the present study were to: 1) compare the expression spinal cord, leading to muscle atrophy, paralysis, and death. Recent studies show that impairment of the blood-brain/spinal cord barrier of markers in vitro for both a low and high number of cell passages from MSCs derived from bone marrow (BM) and from umbilical cord (BBSCB) in both animal models of ALS and ALS patients occurs due to compromised capillary endothelium integrity followed by vascular blood cells (UCB); 2) assess the efficacy of these cells when transplanted into the striata of R6/2 mice. Characterization of the cells was leakage. Additionally, alterations of basement membrane components are noted. The endothelial basement membrane in the vasculature of done using a BD-LSRII flow cytometer (FACS) for different markers, including CD90, stem cell antigen (Sca-1), nestin, CD105, and CD45 the central nervous system (CNS) is composed mainly of collagen type IV and laminin, followed by smaller proportions of collagen types on mice MSCs at different passages. High passaged (≥40) and low passaged (≤7) MSCs from both BM and UCB were transplanted bilat-III, VII, XV, and XVIII, entactins, and proteoglycans. However, little information exists regarding vascular collagen of ALS patients. The erally into the striata (400,000 cells/striatum) of 5-month-old R6/2 mice. Following surgery, all mice were tested in the Morris water aim of this study was to evaluate the basement membrane collagen in brain and spinal cord vessels from ALS patients. Microvascular base-maze (MWM) and rotarod prior to sacrifice at 7 weeks after transplantation, at which point their brains were processed using immunohisto-ment membrane was examined in gray matter postmortem tissue of the brain stem (medulla) and spinal cords (cervical and lumbar) from chemistry (IHC). Our in vitro results indicated that CD90 expression decreased, and Sca-1 increased as the number of passages increased. ALS patients (n = 12) and age-matched controls (n = 8), obtained from human tissue banks (Human Brain and Spinal Fluid Resource Center, This indicates that there are significant changes in cell characterization over passages. Our in vivo results revealed that only R6/2 mice receiv-Los Angeles, CA, and NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD), via ing high passaged BM-MSCs had longer latencies to fall off the rotarod, while all transplant groups had decreased latencies to find the electron microscopy. Collagen expansion was measured in vessel quadrants (n = 5) in the medulla, cervical, and lumbar spinal cord from hidden platform in the MWM task. Our IHC results indicated greater survival of BM-MSCs, but less neuronal differentiation (as quantified each ALS patient and control via electron micrographs. Tissue samples were also stained with 0.1% Sirius Red, confirming collagen in the by NeuN labeling), relative to transplanted UCB-MSCs. Our results suggest that high passaged BM-MSCs provided increased behavioral vascular basement membrane. Our results showed a significant increase (p < 0.0001), 2-2.5 times, of basement membrane collagen ac-efficacy and transplant survivability, while UCB-MSC transplants provided more neuronal differentiation. As such, our results indicate that cumulation in the majority of medulla, cervical, and lumbar spinal cord microvessels from ALS patients (0.9273 ± 0.06, 2.5832 ± 0.13, the source of MSCs and the number of cell passages are critical variables to be considered for transplantation therapies. and 2.1386 ± 0.10 µm, respectively) compared to controls (0.5807 ± 0.049, 0.9538 ± 0.103, and 0.9560 ± 0.095 µm, respectively). Histo-This work is supported by the John G. Kulhavi Professorship in Neuroscience, Central Michigan University Neuroscience Program pathological staining for Sirius Red confirmed collagen basement membrane expansion in ALS patients, corroborating the ultrastructural and the Field Neurosciences Institute.
Flow cytometry and immunohistochemistry data indicate that more present in neurons under normoxic or OGD conditions. We have previously observed that expression of peroxiredoxin 5 (Prdx5), vascular GFP + /CD11b + BMDM cells infiltrate the brain parenchyma following CCL2 overexpression compared with the contralateral hemisphere of cell adhesion molecule 1 (Vcam1), chemokine ligand 1 (Cxcl1), paired box 6 (Pax6), doublecortin-like kinase 1 (Dclk1), phosphatase 3 regu-AAV9-CCL2-injected or control animals (p < 0.001, t-test). CCL2 overexpression led to significant activation of brain resident microglia latory subunit B (Ppp3r1), and stathmin-like 4 (Stmn4) genes were induced in the neurons by the presence of HUCB under normoxic or in both brain regions as shown by CD45 staining of the brain tissue with threefold higher activation in hippocampus and twofold in cortex OGD conditions. We will further examine whether Akt signaling is critical for the induction of these genes by HUCB cells. These results compared to control. Using major histocompatibility complex II (MHCII) staining, we confirmed the same level of activation of micro-demonstrate that the activation of the Akt protein is essential for the HUCB-dependent survival of neurons exposed to OGD. glia, especially around the region of injection. Interestingly, we observe that overexpression of CCL2 in the brain can drive the expres-This study was supported by NIH Grant #R01NS52839 (A.E.W.) . A.E.W. is a consultant to Saneron CCEL Therapeutics, Inc. and is an sion of alternative activation state markers, YM1 and arginase-1, as well as markers associated with classical activation of microglia such inventor on cord blood patents licensed to Saneron CCEL Therapeutics, Inc. as calgranulin B (S100B) and IL-1β. We also measured the cytokine/ chemokine levels in the treated brain and found significant increases in interleukin-6 (IL-6), granulocyte colony-stimulating factor (G-CSF), and eotaxin levels, but not in tumor necrosis factor-α (TNF-α) or in-Chronic Exposure of Silica Dust (SiO 2 Nanoparticles) Exacerbate terferon-γ (IFN-γ). Moreover, the real-time PCR analysis confirmed Stress Symptoms, Cognitive Dysfunction, and Brain Pathology increases in gene expression of arginase-1 (2.4-fold), YM1, (2.7-fold), Following Hyperthermic Brain Injury and signal regulatory protein beta (Sirpb, 17-fold), but a decrease in macrophage receptor with collagenous structure (MARCO) gene ex-H. S. Sharma,* A. Sharma,* and D. F. Muresanu † pression (0.6-fold) compared to controls following CCL2 overexpression. Monocyte chemoattractant protein (CCL2) overexpression led to *Department of Surgical Sciences, Anesthesiology and Intensive GFP + /CD11b + BMDM infiltration into the brain as well as recruitment and activation of CD45-and MHCII-positive macrophages. Pheno-Care Medicine, University Hospital, Uppsala University, typic characterization together with gene/protein expression profile of Uppsala, Sweden brain tissue by using multiple microglial markers demonstrated both †Department of Neurology, University of Medicine and Pharmacy, M1 and M2 activation markers of microglia in response to CCL2.
Cluj-Napoca, Romania Overall, the results from this study present both a challenge and an opportunity for targeting peripheral monocyte/macrophage cells and Exposure of silica dust (SiO 2 nanoparticles, 20-80 nm) to humans evaluating their role in modifying the pathogenesis of AD and other living in desert areas could influence their mental health function as inflammatory diseases.
SiO 2 nanoparticles may get access into the human body through inha-Supported by NIH grants AG 15490 and AG25711.
lation. Thus, it appears that humans exposed to desert environment may have altered physiological conditions due to the presence of SiO 2 nanoparticles and thus react differently to heat stress or trauma biolog-Human Umbilical Cord Blood (HUBC) Cells Protect Neurons ically compared to nonexposed subjects. This idea was examined using Following Oxygen Glucose Deprivation Through Activation a rat model of hyperthermia simulating these environmental conditions of the Akt Pathway and exposure to SiO 2 (40-50 nm) nanoparticles. Rats were exposed to SiO 2 nanoparticles suspended in Tween 80 (10, 20, 30 mg/kg, IP) once daily for 10 days. On day 10 nanoparticles or vehicle (Tween 80) M. Shahaduzzaman,* V. Mehta,* J. E. Golden,* † D. Rowe, † treated animals were subjected to 4-h heat stress in a biological oxygen K. R. Pennypacker, † and A. E. Willing* † demand incubator (BOD) maintained at 38°C (relative humidity 45-50% and wind velocity 20-25 cm/s). After heat exposure, the animals *Center for Excellence in Aging & Brain Repair, Department were examined for cognitive function using a Rota rod, walking on of Neurosurgery and Brain Repair, University of South Florida mesh grid, inclined plane angle test, and stride length. In addition, College of Medicine, Tampa, FL, USA their blood-brain barrier (BBB) function was examined using Evans †Department of Molecular Pharmacology and Physiology, blue albumin and radioiodine tracers. Brain edema was measured us-University of South Florida College of Medicine, Tampa, FL, USA ing water content and cell injuries were examined using Nissl staining. Rats treated with nanoparticles (30 mg) when exposed to 4-h heat stress exhibited greater hyperthermia (42.21 ± 0.14°C; normal animals The Akt pathway plays a key role in mediating neuronal cell survival. Here we test the hypothesis that the neuroprotective effect of 40.67 ± 0.21°C, p < 0.001) and behavioral dysfunctions. Thus, these rats could not maintain themselves on a Rota rod for more than 60 ± HUCB following oxygen glucose deprivation (OGD) is mediated through activation of the Akt signaling pathway. Neurons were iso-3 s (normal animals 80 ± 6 s, p < 0.001). The inclined plane angle test was also lower for these nanoparticle-treated animals (38 ± 6°, normal lated from E17 Sprague-Dawley rats and cultured in Neurobasal media for 6 days. After 6 days, the cultures were then exposed to one of 45 ± 6°, xlmp0.001) and placement error was significantly increased (48 ± 5%, normal 34 ± 6%, p < 0.001) in these rats compared to un-eight experimental conditions: normoxia, normoxia + HUCB cells, normoxia + Akt inhibitor (AktI), normoxia + HUCB + AktI, OGD, treated heat-stressed rats. The nanoparticle-treated rats exhibited higher magnitude of BBB breakdown to Evans blue (2.85 ± 0.12 OGD + HUCB, OGD + AktI, OGD + HUCB + AktI. The HUCB cells were cocultured with a filter insert partitioning them from the neurons. mg%; normal 1.56 ± 0.11 mg%, xlmp0.001) and radioiodine (3.57 ± 0.21%, normal 2.34 ± 0.18%, xlmp0.001) tracers and brain edema for-AktI was added to the cultures just prior to OGD exposure. After 20 h, a fluorescein diacetate/propidium iodide (FDA/PI) assay was per-mation (water 82.38 ± 0.23%, normal 80.44 ± 0.21%, xlmp0.001) following heat stress. The number of damaged nerve cells in nanopar-formed and the number of viable cells in each group was determined using Image Pro software. Significant differences were determined us-ticle-treated rats was also significantly higher (cortex 183 ± 4; hippocampus 105 ± 8; cerebellum 234 ± 12; thalamus 156 ± 12; hypo-ing ANOVA [F(7, 32) = 96.84, p < 0.001]. Survival in the mormoxic culture was 67 ± 3% compared to 80 ± 2% in the normoxia neuron-thalamus 87 ± 12; spinal cord 86 ± 8) than in normal animals (cortex 88 ± 6; hippocampus 65 ± 4; cerebellum 89 ± 6; thalamus 77 ± 6; hy-HUCB coculture (p < 0.01) and 40 ± 2% after OGD (p < 0.001). The Akt inhibitor significantly abolished the neuroprotective effect of pothalamus 44 ± 6; spinal cord 36 ± 4, p < 0.001). Taken together these observations suggest that nanoparticle-treated animals are more HUCB both in normoxia (14 ± 2%, p < 0.001) and following OGD (23 ± 2%, p < 0. 001). Immunoblot analysis using phosphoAkt anti-susceptible to heat-induced sensorimotor functions, mental abnormalities, and brain disorders. bodies will be employed to determine the activation of Akt protein also used immunohistochemistry, radioligand binding assays, and non-"Disease-in-a-Dish": The Ability of Stem Cells to Model Pathophysiology In Vitro and Facilitate radioactive in situ hybridization to assess the striatal biochemistry of rats that do or do not express dyskinesia in response to amphetamine Drug Discovery May Represent an Underrecognized Contribution to Neural Therapeutics challenge posttransplantation. Our results demonstrate that amphetamine-induced dyskinesias are pharmacologically distinct from Ldopa-induced dyskinesia. Furthermore, we can find no biochemical E. Y. Snyder correlate of amphetamine-induced dyskinesia; dopamine receptor and fosB expression is normalized by the transplant, and there is no appar-Sanford-Burnham Medical Research Institute, La Jolla, CA, USA ent relationship between their expression and the development of abnormal movements in response to amphetamine. Environmental enrichment does not appear to influence the expression of GID, nor does Stem cells are typically viewed as potential therapeutic agents storage of the graft tissue or the embryonic age of the tissue, but we based on their ability to be transplanted into injured, diseased, or dyshave demonstrated that grafts transplanted into the lateral striatum infunctional organs and promote recovery of function. An underrecogcrease the risk of amphetamine-induced dyskinesia. In summary we nized-and perhaps even more tractable-use of stem cells is their have a model that-despite requiring amphetamine-shows clear simpotential to emulate pathophysiological processes in culture, a concept ilarities with the spontaneous occurrence of clinical GID. Importantly, termed "Disease-in-a-Dish." In this paradigm, "normal" stem cells (eithese studies support the transplantation protocol proposed for future ther undifferentiated or differentiated) can be stressed or perturbed in clinical trials in fetal cell transplantation for PD.
prescribed ways (including via the knock-in of genes), or "diseased" These studies have been supported by grants from the European stem cells (either undifferentiated or differentiated) can be obtained Union (TransEUro) and Parkinson's UK.
from patients with particular diseases under the assumption that the cells will continue to behave abnormally in vitro in a disease-specific manner. The latter option is particularly appealing for conditions in Graft-Induced Dyskinesia in Transplanted Hemiparkinsonian which authentic and/or predictive animal models do not exist. The
Mice and Rats: A Pharmacological Manipulation
stem cells can be used to (a) study underling molecular mechanisms of disease; (b) to identify drug targets, diagnostic, or prognostics; (c) to identify protective agents and/or mechanisms; (d) to identify and G. A. Smith,* E. L. Lane, † and S. B. Dunnett* test drugs or "leads"-to-drugs. Drug discovery is typically carried out through the unbiased high-throughput screening of small drug-like *Brain Repair Group, Cardiff University, Cardiff, UK molecule libraries. When stem cells are used in such paradigms, it is †Welsh School of Pharmacy, Cardiff University, Cardiff, UK the drugs-rather than the cells themselves-that are used to treat patients. The stem cells to be studied may be obtained from three The neural transplantation of embryonic dopamine-rich cells into sources: (a) from somatic stem cells isolated directly from the organ Parkinson's disease (PD) patients has led to symptomatic improveof interest (e.g., brain, spinal cord, tumor); (b) from the inner cell mass ments. However, clinical trials have shown that a proportion of paof embryos diagnosed as bearing a disease following preimplantation tients develop debilitating dyskinesias in response to the graft, irregenetic diagnosis (PGD) (i.e., embryonic stem cells); (c) from endspective of L-3,4-dihydroxyphenylalanine (L-dopa) treatment. These differentiated somatic cells (e.g., skin fibroblasts) biopsied from pahyperkinesias can be mimicked experimentally in rats but it is unclear tients with a particular disease and reprogrammed back to pluripotence whether these can be modeled in the mouse due to practical difficul-(i.e., induced pluripotent stem cells). The latter strategy has received ties, high mortality rates, and small graft sizes. Also the mechanistic the most attention of late because of its relative ease and accessibility. similarity between graft-induced dyskinesia (GID) and L-dopa-induced This symposium will feature investigators at the forefront of Diseasedyskinesia (LID) is currently unknown. This may be elucidated by the in-a-Dish technology. Importantly, the following unresolved questions pharmacological modulation of GID with substances known to affect will be addressed. 1) Can a disease process be faithfully modeled in LID in rodent models. Thirty-two rats and 27 mice were unilaterally vitro, in isolation from the rest of the body, or does disease expression lesioned with 6-hydroxydopamine (6-OHDA), targeted to the median require the complete in vivo environment (an intact immune and vasforebrain bundle and primed with L-dopa (3 weeks). All animals recular system as well as multiple lineages and cell types, etc.)? 2) Can ceived ventral mesencephalon tissue transplant (E14 rats and E13 a phenotype be observable in vitro that reliably distinguishes normal mice) into the denervated striatum. Abnormal inhibitory movements from "diseased" cells in a meaningful manner and that is attributable were subsequently triggered by amphetamine (2.5 mg/kg) and scored to the disease's pathophysiology? 3) Can the phenotype account for based on a modified version of the Cenci and Lundblad rating scale.
the disease manifestations in a patient and can it be a useful drug A subset of rats were coadministered with a pharmacological chaltarget against which therapeutic molecules can be screened? 4) Does lenge of either: raclopride (0.5 and 2 mg/kg), SCH-22390 (0.05 and the reprogramming or culturing process change the cells such that the investigated. First, by the time PD is diagnosed, significant striatal DA proves survival and nerve fiber growth in grafted dopamine neurons. In VM tissue culture, dopamine nerve fiber production is hampered in depletion and associated spine pathology exists. Thus, for Ca 2+ channel blocker therapy to have an impact, particularly in patients with ad-cultures derived from Gdnf knockout (K/O) compared to wild-type; however, little is known about the long-term maintenance of the nigro-vanced disease, it will be necessary to reverse existing spine loss. Second, spine dynamics are classically associated with neuroplasticity, striatal dopamine system in the absence of GDNF. Therefore, this study was undertaken to investigate the long-term survival of intraven-which decreases with advanced age, a factor associated with idiopathic PD. In the current study, we tested whether normalizing intraspine tricular cografts of VM and lateral ganglionic eminence (LGE) from Gdnf K/O. The results revealed that a similar number of tyrosine hy-Ca 2+ with the Ca 2+ channel blocker, nimodipine, in severely parkinsonian rats after the initial spine loss has occurred would allow for re-droxylase (TH)-positive neurons were counted in VM from all Gdnf genotypes at 3 months postgrafting. At longer time points (6 and 12 covery of spine density. A small pilot study indicated that there is the capacity to recover spine density when nimodipine is administered months), the number of TH-positive neurons was significantly reduced in Gdnf heterozygous (Hets) transplants, and the entire VM/LGE co-after spine loss in young parkinsonian rats. A larger study was undertaken to examine whether a difference in ability to recover spines ex-transplants had degenerated in Gdnf K/O-derived grafts. The TH-positive innervation of the striatal cograft was patchy and dense in wild-ists between young (3 months) and aged (22 months) subjects. The ability of MSN to regain a normal complement of spines following type transplants, while it was less dense and widespread in Gdnf K/O grafts. The dense TH-positive zones in wild-type-derived striatal co-cessation of aberrant calcium signaling and the ultrastructural integrity of remodeled synapses is being compared between age groups. grafts overlapped with areas demonstrating dense clusters of DARPP-32 (dopamine cAMP-regulated phosphoprotein of 32,000 kDa)-posi-Changes in Cav1.3 channel protein with age are also being examined. The ability to reestablish normalized target morphology may allow for tive neurons, while no dense DARPP-32-positive clusters were found in Gdnf K/O transplants. To further investigate whether the poor de-improved symptomatic therapy for patients with PD.
Supported by NINDS (P50NS058830). velopment of the striatal tissue affected the survival of VM, single VM grafts from the Gdnf genotypes were investigated, and magnetic resonance imaging (MRI) scans were performed to follow the volume Serum Metabolite Biomarkers for the Diagnosis of the transplants. At 2 months, the volume of the Gdnf K/O transof Ischemic Stroke plants was reduced while the wild-type grafts had grown. At 6-7 months, degenerating areas were found in the MRI scans of grafts L. L. Stone,* † J. B. Nikas,* † E. Perkins,* † Z. Nan,* † from Gdnf Hets, which also was confirmed by histological evaluations. and W. C. Low* † Thus, the nigrostriatal system develops in the absence of GDNF, although the striatal organization appears malformed, and both the striatum and the VM dopamine neurons need GDNF for maintenance dur-*Graduate Program in Neuroscience, Department of Neurosurgery, ing adulthood. University of Minnesota, Minneapolis, MN, USA †Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA Stroke is one of the leading causes of death and disability in the Human Retinal Pigment Epithelial Cell (HRPEC) Cografts US. Presently, a definitive, quick diagnosis of stroke in the clinical Improve Survival of Xenografted Dopaminergic Human setting has yet to be developed to exclude conditions that can mimic Embryonic Stem Cells (hES), Diminish Host Inflammation, a stroke. In addition, current methods of stroke diagnosis are often and Immune Response time consuming and costly, thus affecting the short time window in which treatment of stroke is most beneficial to the patient. There is T. Subramanian,* K. Venkiteswaran,* A. Rowlands,* therefore a great need for a quick, noninvasive diagnostic tool that will R. Ramachandra,* C. Lieu,* A. Rao,* J. Chen, † and W. Freed † accurately diagnose stroke in its acute phase in order to facilitate timely treatment and improved outcome for the patients. We postu-*Penn State College of Medicine, Hershey, PA, USA lated that metabolites in serum could be used as biomarkers to aid in †National Institute for Drug Abuse, Baltimore, MD, USA the diagnosis of ischemic stroke. To test this hypothesis we have analyzed the blood of Sprague-Dawley rats that have undergone ischemic Human embryonic stem cell (hES) striatal grafts without immunostroke to identify changes in the metabolomic profile that are indicasuppression in adult animals is accompanied by a cell-mediated tive of stroke. Serum was analyzed using 1 H nuclear magnetic resochronic immune response and graft rejection. hES transplants into the nance spectroscopy ( 1 H-NMR) to obtain a high-throughput screening striatum demonstrate massive cell death even with cyclosporine (CSA) of the metabolites present in the serum of animals 24 h following immunosuppression. In contrast, human retinal pigment epithelial cell stroke. Our preliminary analysis has shown a distinct change in the (hRPEC) striatal transplants survive without any need for immunosupoverall metabolomic profile in the serum of rats following stroke. Spepression and these cells appear to secrete immunosuppressive subcifically, we have noted downregulation in the expression of 18 metabstances that promote graft survival. We tested the hypothesis whether olites, including acetate, citrate, creatine phosphate, and glucose. Anal-hRPEC cografted with hES is capable of avoiding a deleterious host ysis of changes in the metabolome allows us to look at the functional immune response and whether hRPEC/hES cografts can provide trochanges that are occurring systemically following stroke, and may prophic support to the hES graft using two cohorts. In cohort 1 histologivide further insight into the pathophysiology of stroke. Studying the cal studies were performed after 18-day survival postbilateral striatal metabolome could provide potential biomarkers for the diagnosis of transplants in three groups of animals: group 1, hRPEC cografted with stroke in early stages. If translated to the clinic, this information could hES (n = 4); group 2, hES transplants with daily cyclosporine (CSA) allow prompt and effective treatment of this devastating disease. treatment (n = 2); and group 3, hES transplants without any immunosuppression (n = 4). In addition, we directly compared the effects of GDNF Is Required for Maintenance of Dopamine and Striatal systemic immunosuppression to cografts of hRPEC/hES in the 6-Neurons in the Nigrostriatal System hydroxydopamine (6-OHDA)-lesioned hemiparkinsonian rat and the differential effects in any parkinsonian behavior over a period of 3 I. Strömberg, M. Chermenina, N. Nevalainen, P. Schouten, months. This second cohort consisted of group 4, hRPEC cografted A. Rehnmark, O. Greger, and F. Marschinke with hES (n = 6), and group 5, hES with daily CSA treatment (n = 4). Each hemisphere received a total of 480,000 hES cells alone or in conjunction with 60,000 hRPEC cells divided equally into three tar-Department of Integrative Medical Biology, Umeå University, gets. All animals had excellent placement of striatal grafts and cellular Umeå, Sweden TH expression. Estimation of TH-positive cell bodies using systematic random sampling and the optical fractionator method yielded a mean Glial cell line-derived neurotrophic factor (GDNF) is a potent factor for ventral mesencephalic (VM) dopamine neurons. GDNF im-of 78,738 cells/hemisphere (CE = 0.13) for the hES-alone cohort. In
